ctri data base india icmr

Clinical trial registry database India/WHO

1 Trial 1 Completed

2 Trial 2

3 Trial 3 Completed

4 Trial 4

5 Trial 5 Completed

6 Trial 6

7 Trial 7

8 Trial 8 Completed

9 Trial 9

S. no

Trial No.

UTRN.WHO CTRI No.and Date

Status of TrialWHO

TEMP UTRN 110920818-21122008400346

CTRI/2008/091/000298, 27-05-2009

TEMP UTRN 084547349-070120101616999

CTRI/2010/091/000016, 13-01-2010

Open to recruitment

TEMP UTRN 013618768-27082008248338

CTRI/2008/091/000154, 12-06-2009

TEMP UTRN 033922579-12022009483602

CTRI/2009/091/000066, 09-03-2009

Open to recruitment

TEMP UTRN 023324110-21032009531943

CTRI/2009/091/000111, 13-05-2009

TEMP UTRN 095106093-15012009436721

CTRI/2009/091/000022, 18-06-2009

Open to recruitment

TEMP UTRN 065751749-0701201016201816

CTRI/2010/091/000020, 01-02-2010

Closed to recruitment of participants

TEMP UTRN 085037996-09012010162852

CTRI/2010/091/000028, 15-01-2010

TEMP UTRN 110121271-09012010162952

CTRI/2010/091/000029, 23-04-2010


10 Trial 10

11 Trial 11

12 Trial 12

13 Trial 13

14 Trial 14

15 Trial 15

16 Trial 16

17 Trial 17

18 Trial 18

19 Trial 19

20 Trial 20

TEMP UTRN 115252025-09012010163152

CTRI/2010/091/000031, 23-04-2010


TEMP UTRN 080354168-231220091572599

CTRI/2009/091/001071, 11-05-2010

Open to recruitment

TEMP UTRN 122452186-10102008301599

CTRI/2008/091/000204, 11-02-2009

Open to recruitment

TEMP UTRN 035051948-16042009602241

CTRI/2009/091/000182, 13-05-2009

Open to recruitment

TEMP UTRN 053105122-16042009603241

CTRI/2009/091/000183, 13-05-2009

Open to recruitment

TEMP UTRN 061806049-16042009604241

CTRI/2009/091/000184, 13-05-2009

Open to recruitment

TEMP UTRN 033519060-150520097221180

CTRI/2009/091/000279, 27-05-2009

Open to recruitment

TEMP UTRN 111634368-1904201020223272

CTRI/2010/091/000401, 30-04-2010

Open to recruitment

TEMP UTRN 105647370-2112200757179

CTRI/2007/091/000043, 28-04-2008

Open to recruitment

TEMP UTRN 111501559-22042008122327

CTRI/2008/091/000047, 30-04-2008

Not yet recruiting

TEMP UTRN 060332551-0801201016251569

CTRI/2010/091/000025, 09-07-2010

Open to recruitment

21 Trial 21

22 Trial 22

23

24

25

26

27

28

29

30

31

TEMP UTRN 060355560-0801201016261569

CTRI/2010/091/000026, 10-03-2010

Open to recruitment

TEMP UTRN 033138488-100720102402235

CTRI/2010/091/001098, 13-07-2010

Not yet recruiting

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499

500


5/27/2009 4/8/2010

1/13/2010 3/26/2010

acute renal failure

6/12/2009 12/23/2009

3/9/2009 4/23/2009

5/13/2009 3/18/2010

6/18/2009 6/24/2010 Septic Shock

2/1/2010 2/1/2010 H1N1

1/15/2010 4/19/2010 H1N1

1/1/2007 5/13/2010 H1N1

Last Verified on

Last Updated on

Speciality-Subspeciality

Congestive heart failure

Chronic Obstructive

Pulmonary Disease

Chronic Obstructive

Pulmonary Disease

Chronic Obstructive

Pulmonary Disease

4/23/2010 5/13/2010 H1N1

5/11/2010 5/5/2010 Shock

2/11/2009 2/11/2009

5/13/2009 5/15/2009

1/1/2007 5/13/2009

5/13/2009 4/27/2009

5/27/2009 5/26/2009

4/30/2010 6/14/2010

4/28/2008 5/20/2010

4/30/2008 1/1/2007

1/1/2007 7/9/2010

cardiac arrhythmias

Pulmonary Arterial Hypertension





life-threatening illness



3/10/2010 3/5/2010

7/13/2010 7/13/2010



Public Title StudyWHO* Scientific Title of StudyWHO*

28

31

200

1696

100

72

360

T. sample

size

Cardiac rehabilitation and quality of life in congestive heart failure

The effects of exercise based cardiac rehabilitation on quality of life in

congestive heart failure

A clinical trial to study the effects of a drug, Gammaplex, in patients

with chronic Idiopathic Thrombocytopenic Purpura

A Phase III, Multicenter, Open-Label Study To Evaluate the Efficacy and

Safety of GAMMAPLEX® in Chronic Idiopathic

Study to assess efficacy & safety of doxofylline 400 mg twice daily

versus doxofylline 800 mg ER once daily in the treatment of

A open-labelled, prospective, randomized, two-arm, parallel group

4-week clinical study to assess efficacy & safety of doxophylline

Efficacy and Safety of Indacaterol in Adults (40 Years and Above)

With Chronic Obstructive Pulmonary Disease (COPD)

A Phase III, 26-Week Multi-Center Randomized Double-Blind, Placebo-Controlled, Parallel-Group Study to

Assess the Efficacy, Safety and A clinical trial to study the effects

of two drugs, fixed dose combination of Formoterol

fumarate & Mometasone furoate

An open label, comparative, multicentric study to assess the

efficacy and safety of fixed-dose combination of Formoterol fumarate

Efficacy and Safety of Drotrecogin Alfa (Activated) in

Adult Patients with Septic Shock

A Randomized, Double-blind, Placebo-controlled, Multicenter,

Phase 3 Study of Drotrecogin Alfa (Activated) Administered as a

Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted

Vaccine in Healthy Adults in India

Bridging Study on Safety and Immunogenicity of an Intramuscular

Inactivated, Split Virion Swine-Origin A/H1N1 Influenza Non-

A clinical study to Evaluate The Safety, Tolerability And

Immunogenicity Of Three Formulations (15µg Without

A Randomized, Double Blind, Comparative, Phase I Study To

Evaluate The Safety, Tolerability And Immunogenicity Of Three

A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A

A Randomized, Double Blind, Comparative, Phase II/III Study to Evaluate the Immunogenicity and Safety of Three Formulations [15

360

3000

2000

180

180

72

200

180

500

A Phase II/III clinical Study to Evaluate the Immunogenicity and Safety of Three Formulations of Monovalent H1N1 Influenza A

A Randomized, Double Blind, Comparative, Phase II/III Study to Evaluate the Immunogenicity and Safety of Three Formulations [15

Medtronic- Shock-Less study to determine whether periodic

reports delivered to study centers can increase use of shock

Shock-Less study: A prospective, non-randomized, multi-centre post

market clinical trial.

PANARM HF : A clinical registry to understand the disease profiles

of patients who suffer from cardiac arrhythmias and/or heart

PANARM HF -A prospective, multi-center, non-interventional to collect

(at the referring physician stage), data pertaining to the demographic,

SR-PAAS - Sitaxentan Efficacy and Safety Trial With a

Randomized Prospective Assessment of Adding Sildenafil

A Phase 3, Multi-Center, Randomized, Double-Blind, Placebo-

Controlled, Safety And Efficacy Study Of Sitaxsentan Sodium In

Open-Label Study Providing Monotherapy (Sitaxsentan) and

Combination Therapy (Sitaxsentan+Sildenafil) to

A Phase 3, Multi-Center, Open Label Study To Evaluate The Long-Term Safety Of Monotherapy Sitaxsentan Sodium And Combination Therapy

Study Looking at Combination Therapy (Sitaxsentan+Sildenafil)

vs. Monotherapy (Sitaxsentan Alone) SR-PAAS -Sitaxentan

A Phase 3, Multi-Center, Randomized, Double-Blind, Efficacy And Safety Study Of Monotherapy

Sitaxsentan Sodium Versus A Research Study To Assess The

Effectiveness And Safety Of Different Doses Of Oral PF-

00489791 In The Treatment Of

A Phase 2a, Randomized, Double Blind, Placebo-Controlled, Parallel

Group Study Investigating The Dose-Response Of PF-00489791 On Acute

An open label clinical trial to study the effects of long term

administration of study drug to Improve Clinical Outcome in

Long term single-arm open label extension study of the SERAPHIN

study to assess the safety and tolerability of ACT-064992 in

Approx 699

A study to determine the safety and activity of a novel oral agent, AV-951, in patients with kidney cancer To determine the safety

A Phase 2, Placebo-Controlled, Randomized, Discontinuation Trial of AV-951 in Patients With Renal Cell

Carcinoma A clinical trial to study the effects

of 2 Ayurvedic formulations, containing Ashwagandha, Brahmi and Amalaki on the physical and

A Proof of Concept prospective, double-blind, placebo controlled, comparative, randomized, parallel

group, multi-centric clinical study to An Extension Treatment Protocol

for Subjects who have Participated in AV-951-09-301

study

An Extension Treatment Protocol for Subjects who have Participated in a

Phase 3 Study of Tivozanib vs. Sorafenib in Renal Cell Carcinoma

500

900

A Clinical Trial Study to Compare Tivozanib to Sorafenib in Subjects

With advanced Renal Cell Carcinoma

A Phase 3, Randomized, Controlled, Multi-Center, Open-Label Study to Compare Tivozanib (AV-951) to

Sorafenib in Subjects With Advanced A clinical trial to study the effects

of a new drug and compare the effect of BIBW 2992 along with

paclitaxel and investgators choice

Phase III randomized trial of BIBW 2992 plus weekly paclitaxel versus

Investigator?s choice of chemotherapy following BIBW 2992

Phase Site 1 Site 2 Site 3 Site 4

1

Phase 3 10

Phase 4 1

Phase 3 2

Phase 3 5

Phase 3 15

Phase 3 3

Phase 1 1

7

Esti trial duration

total Sites no

Not Applicable

1 Years Department of physiotherapy

2 Years

Months Government Medical College & Hospital

Months HEALTH AND RESEARCH CENTRE

SDS Tuberculosis and

Chest & TB Hospital

Mahatma Gandhi Nationa

ASHRAI ASSOCIATES,

Indore Chest Centre, Indore

4 Years Grant Medical Foundation, Ruby Hall

Deenanath Mangeshkar

KEM Hospital & Researc

Dept. of Pulmonary and Critical

12 Months Post Graduate Institute of Medical Education

Department of Pediatrics

Professor and Head, Pediatri

85 Days Fortis Clinical Research Ltd

Phase 2/Phase 3

95 Days ICH (Institute of Child Health)

GR Medical College

G.S.V.M College

Dr.D.Y.Patil Medical College

7

Phase 4 6

8

Phase 3 5

Phase 3 5

Phase 3 5

Phase 2 3

Phase 3 6

Phase 2 5

Phase 2 4

Phase 3 12

Phase 2/Phase 3

95 Days M.G.M Medical College and Chacha

GR Medical College

Dr. Ritabrata Kundu

G.S.V.M College

4 Years Max Devki Devi Heart & Vascular Institute

Max Balaji Hospital

Sri Chitra Insitute for

Escorts Heart Institute &

Not Applicable

2 Years C-4/3 Vasant Vihar

Escort Heart & Research

Heart Care Clinic

Fortis Escorts Hospital

Months Meenakshi Mission Hospital and Research

The Heart Care Clinic

Poona Hospital & Researc

Heart First Cardiac And

58 Months Kovai Medical Center and Hospital

Meenakshi Mission Hospita



27 Months Kovai Medical Center and Hospital

Meenakshi Mission Hospita



8 Months Bankers Heart Institute

Department Of Cardiology, Sri

Department Of Cardiology,

4.5 Years KEM Hospital & Seth G.S. Medical

G. B. Pant Hospital

P.D Hinduja National


2 Years Jaslok Hospital & Research Centre

Rajiv Gandhi Cancer Institute

Christian Medical College

Dept. of Oncology, Tata Memori

12 Months TNMC & BYL Nair Hospital, Mumbai

Seth G.S. Medical College

Deccan College of Medical

Vydehi Institute of Medical

2 Years Rajiv Gandhi Cancer Institute and Research

Searoc Cancer Centre,

Shyam Hematology- Oncolo

Mehdi Nawaz Jung insitute,

Phase 3 12

Phase 3 5

2 Years Rajiv Gandhi Cancer Institute and Research

Searoc Cancer Centre,

Shyam Hematology- Oncolo

Mehdi Nawaz Jung insitute,

2 Years Grant Medical Foundation

Tata Memorial Hospita

Dr. Kamakshi Memori

Bhagwan Mahaveer

Site 5 Site 6 Site 7 Site 8 Site 9 Site 10

L.T.M. Medical College &

L.T.M. Medical College &

Narayana Hrudayalaya

Escorts Heart Institute &

Indraprashtha Apollo Hospita

Apollo Hospitals

Dept. of Anaesthesiology,

Mediciti Hospital, 5-9-

M.G.M Medical College and

Sant Dnyaneshwar Medical

K.C General Hospital

Dr.D.Y.Patil Medical College

Sant Dnyaneshwar Medical

K.C General Hospital

Medanta Heart Institute,

Postgraduate Institute of

Fortis Hospital, Mohali

Escorts Hospital & Researc

Escorts Hospital

Indraprastha Apollo Hosp

Kovai Medical Center and Heart First Cardiac And Heart First Cardiac And

Care Hospital

Apollo Hospital Internat

Orchid Nursing Home


Orchid Nursing home

Shatabdi Superspeciality

Deenanth Mangeshkar

Chatrapati Shahuji Maharaj

Oyster and Pearl hospital

Mahavir Cancer Sanstha

S.M.S Medical College &


Orchid Nursing home


Deenanth Mangeshkar

Chatrapati Shahuji Maharaj

Oyster and Pearl hospital

Mahavir Cancer Sanstha

S.M.S Medical College &

Kota Cancer Hospital and


1 Trial 1 2/6/2009 2/4/2009

2 Trial 2 9/24/2009 7/27/2009

3 Trial 3 1/13/2010 5/25/2010

4 Trial 4 6/28/2010 6/24/2010

5 Trial 5 6/25/2010 5/19/2010

6 Trial 6 5/20/2010 5/18/2010

7 Trial 7 5/24/2010 5/24/2010

8 Trial 8 6/28/2010 7/20/2010

9 Trial 9

S. no

Trial No.

UTRN.WHO CTRI No.and

Date

Status of

TrialWHO

Last Verified on

Last Updated on

TEMP UTRN 112432317-

15112008348703

CTRI/2008/091/000250, 06-

02-2009

Completed


13022009485959

CTRI/2009/091/000068, 24-

09-2009

Completed


0601201016142252

CTRI/2010/091/000014, 13-

01-2010

Open to recruitment


2601201016942821

CTRI/2010/091/000090, 28-

06-2010

Not yet recruiti

ng


1703201018803114

CTRI/2010/091/000264, 25-

06-2010

Open to recruitment


0903201018463090

CTRI/2010/091/000231, 20-

05-2010

Open to recruitment


1404201020043393

CTRI/2010/091/000383, 24-

05-2010

Not yet recruiti

ng


2304201020391247

CTRI/2010/091/000417, 28-

06-2010

Open to recruitment

10 Trial 10

11 Trial 11

12 Trial 12

13 Trial 13

14 Trial 14

15 Trial 15

16 Trial 16

17 Trial 17

18 Trial 18

19 Trial 19

20 Trial 20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

43

44

45

46

47

48

49

50

51

52

53

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499


Public Title StudyWHO* Phase

Nephro 25 Phase 4

Nephro 86

Nephro 50 Phase 2

Nephro 100

Nephro 20

Nephro 50

Nephro 50 Phase 4

Nephro 350 Phase 3

Speciality-Subspecialit

y

Scientific Title of StudyWHO*

T. sample

size

OPTIMIZATION OF MYCOPHENOLIC ACID TREATMENT IN RENAL TRANSPLANT RECIPIENTS

PLASMA LEVEL MONITORING OF MYCOPHENOLIC ACID IN RENAL TRANSPLANT RECIPIENTS

"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII

"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII

Phase 2/Phase

3

Effects of strength training in patients undergoing dialysis on biochemical parameters, functional capacity and quality of life.

Impact of short term structured Progressive Resistance Training (PRT) in intradialytic patients (DiaPRE study) in the improvement of small solute clearance,

A clinical trial to study the effect of n-acetylcysteine on endothelial dysfunction,oxidative stress and carotid artery intimal

Effect of N-Acetylcysteine on Oxidative Stress, Endothelial Dysfunction and Carotid Artery Intimal Thickness in Chronic Peritoneal Dialysis

Not Applicabl

e

To study the effect of tacrolimus in patients with lupus nephritis

Tacrolimus as induction therapy for proliferative lupus nephritis

Not Applicabl

e

Comparison of efficacy of Tacrolimus versus Cyclophosphamide in Idiopathic Membranous Nephropathy

Comparison of efficacy of Tacrolimus versus Cyclophosphamide in Idiopathic Membranous Nephropathy

Not Applicabl

e

A clinical trial to compare two protein supplements, egg protein and whey protein in dialysis patients.

Comparison of egg protein vs. whey protein supplements in dialysis patients.

Research Study to demonstrate that intravenous iron isomaltoside 1000 (Monofer®) is non-inferior to

A Phase III, Randomized, Comparative, Open-label Study of Intravenous Iron Isomaltoside 1000 (Monofer®) administered by

Site 1 Site 2 Site 3 Site 4 Site 5 Site 6 Site 7

1

1

1

1

1 AIIMS

1 AIIMS

1

10

Esti trial

duration

total Sites no

1.5 Years

Department of

Pharmacology and

Nephrology4 Months Diabetic

clinic OP,Thiruvananthap

uram medical 3 Years Dialysis

Unit, Central Referral Hospital

12 Months

Dept. of nephrolog

y

6 Months

1 Years

6 Months Aditya Birla

Memorial Hospital

17 Months

Pushpawati

Singhania Research Institute

S.K. Soni Hospital

MAMC College,

Lok Nayak

Hospital

Deenanath Mangeshkar Hospital & Research

P. D. Hinduja National Hospital and Research

Apex Kidney Care Pvt Ltd,

Krishna Institute of Medical Sciences

Site 8 Site 9 PhaseSite 10

T. sample size

Esti trial duration

Department of Nephrology,Osmania General Hospital

Muljibhai Patel Urological Hospital, Dr. Virendra

Department of Nephrology,SMS Medical College


S. no CTRI No.and Date Status of TrialWHO

1 Trial 1

2 Trial 2 Open to recruitment



5 Trial 5

6 Trial 6 Completed

7 Trial 7


9 Trial 9 Completed

Trial No. UTRN.WHO


030920071653

CTRI/2007/091/000013, 23-

11-2007

Closed to recruitment follow up continuing &

closed to recruitment follow up complete


1607200910291247

CTRI/2009/091/000566, 14-

09-2009


030220088248

CTRI/2008/091/000016, 16-

09-2008


1303200898187

CTRI/2008/091/000028, 11-

04-2008


1503200899280

CTRI/2008/091/000029, 30-

05-2008



16042008118313

CTRI/2008/091/000043, 23-

04-2008


18042008120146

CTRI/2008/091/000045, 30-

04-2008



30042008131146

CTRI/2008/091/000056, 13-

05-2008


23072008211450

CTRI/2008/091/000117, 18-

08-2008

10 Trial 10




14 Trial 14

15 Trial 15 Completed




19 Trial 19 Not yet recruiting


13082008222154

CTRI/2008/091/000128, 21-

08-2008



02092008253191

CTRI/2009/091/000159, 30-

04-2009


06112008333191

CTRI/2008/091/000236, 07-

01-2009


10122008377187

CTRI/2008/091/000277, 17-

12-2008


12012009430789

CTRI/2009/091/000016, 16-

01-2009



15012009441872

CTRI/2009/091/000027, 06-

03-2009


19012009446292

CTRI/2009/091/000032, 31-

07-2009


0902200947465

CTRI/2009/091/000057, 11-

02-2009


19022009490146

CTRI/2009/091/000073, 01-

04-2009


24032009535191

CTRI/2009/091/000115, 27-

03-2009



22 Trial 22 Terminated





27 Trial 27

28 Trial 28

29 Trial 29


310320095691134

CTRI/2009/091/000149, 02-

04-2009


1604200960153

CTRI/2009/091/000181, 22-

05-2009


240420096271032

CTRI/2009/091/000207, 05-

05-2009


230420096241220

CTRI/2009/091/000204, 21-

08-2009


20052009739179

CTRI/2009/091/000295, 21-

08-2009


18052009726422

CTRI/2009/091/000283, 06-

11-2009


290420096391230

CTRI/2009/091/000219, 18-

05-2009


10062009804721

CTRI/2009/091/000354, 07-

10-2009



11052009705804

CTRI/2009/091/000262, 08-

06-2009



2707200910571534

CTRI/2009/091/000593, 03-

09-2009




32 Trial 32 Terminated



35 Trial 35

36 Trial 36

37 Trial 37

38 Trial 38 Completed



20052009737872

CTRI/2009/091/000293, 31-

03-2010


300620099401266

CTRI/2009/091/000478, 23-

09-2009


120620098121510

CTRI/2009/091/000362, 25-

06-2009


170620098321569

CTRI/2009/091/000382, 09-

07-2009


230620098811534

CTRI/2009/091/000424, 06-

08-2009


300620099391266

CTRI/2009/091/000477, 23-

09-2009



240620098991632

CTRI/2009/091/000441, 04-

08-2009



020720099581266

CTRI/2009/091/000495, 15-

10-2009



060720099791266

CTRI/2009/091/000516, 07-

12-2009


07072009984146

CTRI/2009/091/000521, 06-

11-2009










49 Trial 49


150720091022146

CTRI/2009/091/000559, 14-

09-2009


2307200910471854

CTRI/2009/091/000942, 18-

11-2009


1108200911031386

CTRI/2009/091/000637, 31-

08-2009


1404201020021247

CTRI/2010/091/000381, 12-

07-2010


3108200911632037

CTRI/2009/091/000694, 25-

09-2009


160920091245191

CTRI/2009/091/000771, 28-

10-2009


2309200912671444

CTRI/2009/091/000790, 30-

09-2009


23092009127236

CTRI/2009/091/000795, 22-

01-2010


2509200912781134

CTRI/2009/091/000800, 14-

10-2009


0510200912951772

CTRI/2009/091/000817, 14-

10-2009



51 Trial 51










1410200913411134

CTRI/2009/091/000857, 20-

10-2009


211020091359789

CTRI/2009/091/000875, 06-

11-2009



301020091377872

CTRI/2009/091/000890, 23-

04-2010


0211200913881220

CTRI/2009/091/000900, 19-

11-2009


081220091524187

CTRI/2009/091/001024, 19-

03-2010


060120101615461

CTRI/2010/091/000015, 17-

02-2010


111220091543129

CTRI/2009/091/001042, 15-

12-2009


1612200915611134

CTRI/2009/091/001060, 23-

12-2009


0902201017471386

CTRI/2010/091/000136, 22-

02-2010


220220101790146

CTRI/2010/091/000177, 09-

03-2010







66

67

68

69


250220101803146

CTRI/2010/091/000190, 13-

04-2010


1903201018941134

CTRI/2010/091/000277, 31-

03-2010


2704201020563461

CTRI/2010/091/000433, 26-

05-2010


2804201020653458

CTRI/2010/091/000441, 17-

05-2010


0806201022371386

CTRI/2010/091/000610, 29-

06-2010


2806201023542133

CTRI/2010/091/001052, 12-

07-2010

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499


Public Title StudyWHO*

11/9/2008 17-04-2009 Onco

14-02-2009 1/9/2009 Onco

16-09-2008 30-12-2008 Onco

11/4/2008 1/7/2008 Onco

30-05-2008 23-10-2008 Onco

23-04-2008 1/1/2007 Onco

30-04-2008 23-02-2009 Onco

13-05-2008 24-02-2009 Onco

18-08-2008 18-07-2009 Onco

Last Verified on

Last Updated on


.A clinical trial to study the effects, (side effects and efficacy) of two combinations of chemotherapy drugs, (Paclitaxel, ifosfamide and Treatment of patients with Aggressive Lymphoma following Self Stem Cell Transplantation

Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD) / Carboplatin versus without in Patients with Advanced A double blind clinical trial comparing the study drug and placebo as second line therapy for treatment of Locally Advanced or Metastatic Non A study to assess the effect of two chemotherapy drugs (paclitaxel and Cisplatin) along with radiation in treating cancer of the uterine cervix Effect of Praneem polyherbal formulations against Infection of HPV in Uterine cervix.

To compare two advanced high-precision radiotherapy techniques in head and neck cancers.

Effect of no head shaving in Neurosurgery on the risk of wound infection

A clinical trial to study the efficacy of probiotic Lactobacillus brevis lozenges in preventing radiation and chemotherapy induced oral

21-08-2008 10/6/2010 Onco

22-09-2008 30-04-2009 Onco

7/1/2009 1/10/2009 Onco

17-12-2008 11/12/2008 Onco

16-01-2009 3/7/2009 Onco

6/3/2009 25-09-2009 Onco

31-07-2009 30-07-2009 Onco

11/2/2009 10/2/2009 Onco

1/4/2009 25-03-2009 Onco

27-03-2009 30-04-2009 Onco

Study of Bavituximab plus Paclitaxel and Carboplatin in patients with Non small Cell Lung Cancer.

A phase II clinical trial to study the efficacy and safety of a new drug P276-00 in treatment of recurrent and/or advanced head and neck cancer A Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies A Multinational Randomized Double Blind, Placebo-controlled study to evaluate the efficacy and safety of AVE5026 in the prevention of Venous A clinical trial to study the safety and efficacy of ALD518 in patients with non-small cell lung cancer-related fatigue and cachexia. A post marketing study to study the pharmacokinetic parameters of Factor VIII in patients with Haemophilia A

A clinical trial to study the effect of Cetuximab + Folfiri or Cetuximab + Folfox in patients with KRAS wild type metastatic Colorectal Cancer. A Clinical study to evaluate the effect of Combretastatin A-4 Phosphate in Combination With Paclitaxel and Carboplatin in Comparison To compare the efficacy and safety of low-dose versus standard-dose Filgrastim in chemotherapy induced Neutropenia. A clinical trial to study safety and effects of P276-00 in combination with radiation in patients with recurrent and /or locally advanced head and neck

2/4/2009 1/4/2009 Onco

25-05-2009 5/5/2009 Onco

5/5/2009 2/11/2009 Onco

21-08-2009 18-08-2009 Onco

21-08-2009 20-05-2010 Onco

6/11/2009 12/2/2009 Onco

18-05-2009 14-05-2009 Onco

7/10/2009 16-09-2009 Onco

8/6/2009 1/4/2010 Onco

3/9/2009 31-08-2009 Onco

A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-Based Chemotherapy as First-Line Treatment for Extensive Stage An observational study to see the effect of chemotherapy (docetaxel+platinum)when given prior to surgery/radiotherapy in Locally This study is to evaluate the safety and tolerability of Fluphenazine HCl Monotherapy in patients with Relapsed or Relapsed-and-A clinical trial to study the safety and efficacy of NRC-AN-019 in patients with Chronic Myeloid Leukemia who are not responding or intolerant to A clinical trial to evaluate the safety and efficacy of talaporfin sodium (activated locally using light of a specific wavelength) on liver metastases in patients Study to evaluate the safety and efficacy of TULY (rasburicase) in prevention and treatment of malignancy-associated hyperuricemia A clinical trial to study the effects of Nanoparticle based Paclitaxel drug, which does not contain the solvent cremophor, in advanced breast cancer The purpose of this study is to evaluate the efficacy (disease response) and safety of mapatumumab in combination with bortezomib and Phase 1 safety, efficacy, and pharmacokinetic study of Paclitaxel nano-dispersion injection in subjects with metastatic breast cancer: A A Clinical trial of Investigational Agent in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast Cancer

31-03-2010 16-03-2010 Onco

23-09-2009 2/7/2010 Onco

25-06-2009 25-06-2010 Onco

9/7/2009 1/10/2009 Onco

6/8/2009 30-06-2009 Onco

23-09-2009 21-06-2010 Onco

v04-08-2009 15-12-2009 Onco

15-10-2009 2/7/2010 Onco

v07-12-2009 7/7/2010 Onco

v06-11-2009 1/1/2007 Onco

A clinical phase III trial to study and compare the effects of human Recombinant PTH in post menopausal female with Osteoporosis EGF106708 : Phase-III trial with adjuvant treatment of patients with ErbB2 overexpressing and/or amplified breast cancer who have Study Evaluating Bosutinib-Exemestane Combination Vs Exemestane Alone in Post Menopausal Women With Breast Cancer A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-Irinotecan) Versus Irinotecan in Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects EGF106903 : Phase-III trial in women with HER2/Erb2 positive primary breast cancer using neoadjuvant chemotherapy. A clinical trial to study the pharmacokinetic comparison of two formulations for Intravenous Infusion of Paclitaxel in Indain Patients EGF105485: Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer VEG105424 : Study On Pazopanib When Given With FOLFOX6 (Fluorouracil, Oxaliplatin, Leucovorin) Or CapeOx (Capecitabine, To access the toxicity and efficacy of altered fractionation radiotherapy without chemotherapy in medulloblastoma

14-09-2009 17-08-2009 Onco

18-11-2009 8/6/2010 Onco

31-08-2009 31-08-2009 Onco

12/7/2010 12/7/2010 Onco

25-09-2009 4/2/2010 Onco

28-10-2009 8/1/2010 Onco

30-09-2009 4/3/2010 Onco

22-01-2010 20-04-2010 Onco

14-10-2009 13-10-2009 Onco

14-10-2009 13-10-2009 Onco

Radiation Treatment Of Bladder Cancer With Tomotherapy/ Intensity Modulated Radio Therapy (IMRT) A Study of Neratinib Plus Paclitaxel Versus Trastuzumab Plus Paclitaxel as First-Line Treatment for ErbB-2-Positive Locally Recurrent or Metastatic A bioequivalence study of Capecitabine tablets in patients of Locally Advanced or Metastatic Breast Cancer or Metastatic Colorectal Cancer IY5511 HCL for chronic Myelogenous leukemia

A clinical trial to study the effects of two drugs Peg G-CSF and Grafeel® in the prevention of reduction in neutrophil counts in cancer patients caused A phase II trial to study the efficacy and safety of a new drug P276-00 in the treatment of Mantle Cell Lymphoma

Efficacy Study of XL184 in Adults With Medullary Thyroid Cancer.

A clinical trial to study the safety and efficacy of Non-pegylated Liposomal Doxorubicin (Nudoxa) as compared to doxorubicin in A phase 3 clinical trial to study the long term safety and efficacy of darbepoetin alfa drug in drug induced anemia patients. A clinical trial to study the effect of HKI-272 in subjects with Advanced breast cancer

20-10-2009 14-10-2009 Onco

6/11/2009 24-11-2009 Onco

23-04-2010 21-04-2010 Onco

11/19/2009 11/18/2009 Onco

3/19/2010 3/16/2010 Onco

2/17/2010 1/7/2010 Onco

12/15/2009 12/15/2009 Onco

12/23/2009 1/1/2007 Onco

2/22/2010 4/30/2010 Onco

3/9/2010 3/5/2010 Onco

Phase 1b/2 clinical trial in patients with cancer to Evaluate the Safety and Efficacy of First-line Treatment With Epirubicin, Cisplatin, and A Phase II study in patients with Extensive-Stage Small Cell Lung Cancer.

A 24-week with possible extension, prospective, ulticentre, randomized, double blind, placebo-controlled, 2-parallel group with a A clinical trial to study the effect of NRC-AN-019 in patients with various cancers.

A Study of AVE8062 in Advanced-Stage Soft Tissue Sarcoma After Failure of Anthracycline and Ifosfamide Chemotherapies A clinical trial to study the prediction of result of chemotherapy in Acute myeloid leukemia by evaluating in vitro DNA damage. A clinical trial to study the efficacy of probiotic VSL#3 on chemotherapy-induced diarrhoea in cancer patients recieving A Phase 2 clincial trial to evaluate the Safety and Efficacy of drug FOLFIRI in Combination With drugs AMG 479 or AMG 655 Versus A phase 1 study to evaluate the bioequivalence of two formulation of capecitabine Tablets 500 mg tablets in patients of Breast Cancer or A study to assess the benefit of using growth factors in addition to antibiotics in children with febrile neutropenia

4/13/2010 4/9/2010 Onco

3/31/2010 6/15/2010 Onco

5/26/2010 5/19/2010 Onco

5/17/2010 5/13/2010 Onco

6/29/2010 1/1/2007 Onco

7/12/2010 7/2/2010 Onco

Imatinib pharmacokinetics and its correlation with response and safety in Indian children and adults with chronic phase chronic myeloid leukemia. Phase 3 clinical Study to Compare the Efficacy and Safety of drug product Panitumumab and Cetuximab in Subjects with Previously A clinical trial study of Sunitinib in biliary tract carcinoma after failure of first line treatment

Phase III, Multi-centre, Double Blind, Randomized Placebo Controlled Trial of Aspirin for Duke C and High Risk Dukes B Colorectal Cancers A Clinical trial of Infusion of Nanosomal Docetaxel Lipid Suspension (Intas Pharmaceuticals Ltd.) And Taxotere® in Breast Cancer A phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F uptake by solid tumours using PET

Phase Site 1

100 Phase 2 6

68 Phase 2 4

Phase 3 1

900 Phase 3 1

25 Phase 2 1

20 Phase 2 1

60 Phase 2 1

46 1

300 1


T. sample size

Esti trial duration

total Sites noA Phase IIb RCT of

Neoadjuvant chemotherapy comparing Paclitaxel, ifosfamide and Cisplatin with Paclitaxel,

2 Years Kashyap Nursing Home

Phase II Safety and Efficacy Study of the Monoclonal Antibody CT-011 in Patients with Diffuse Large B-Cell

915 Days Gujarat Cancer and Research Institute

Phase III Randomized Trial of Maintenance Pegylated Liposomal Doxorubicin (PLD) / Carboplatin versus

Months St. John's Medical College & Hospital

A multinational, Randomized, Double-Blind Study Comparing Aflibercept Versus Placebo in Patients

Orchid Nursing Home

Phase II study of Concurrent Chemoirradiation with weekly Paclitaxel and Cisplatin in the treatment

9 Months Department of Radiation Oncology Unit I,CHRISTIAN

MEDICAL COLLEGE ?Study on the efficacy of

Praneem Cream, Praneem Polyherbal tablets on HPV infection of the Cervix-uteri: A

3 Years Cancer Clinic, Department of

Obstetrics & Gynae

Phase II study of 3-Dimensional conformal Radiotherapy (3D-CRT) vs. Intensity Modulated Radiotherapy (IMRT) for

Years Dept. of Radiation Oncology

Head Shaving in Neurosurgery ? Implications on Surgical Site Infection and Cosmesis ? a feasibility

Not Applicable

Years Department of surgical oncology, ACTREC & TMC

A randomized double blind study of efficacy of Lactobacillus CD2 lozenges in preventing radiation and

Phase 2/Phase 3

Years Institute Rotary Cancer Hospital, All

India Institute of Medical Sciences, New Delhi-110029

49 Phase 2 6

54 Phase 2 7

Phase 1 5

3200 Phase 3 2

Phase 2 13

Phase 4 3

260 Phase 2 5

180 8 Mediciti Hospital,

172 Phase 3 1

6 V. N. Cancer Centre

A Phase II Safety and Efficacy Study of Bavituximab Plus Paclitaxel and Carboplatin in Patients

24 Months Orchid Nursing Home, Kolkata

An open label, multicenter Phase II study to evaluate efficacy and safety of P276-00 in Indian subjects with

Years Central India Cancer Research

Institute,11,Shankar Nagar, West High

Court Road,Nagpur - An Open Label, Multicenter Phase I Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In

Years Bhagwan Mahaveer Cancer Hospital,

JLN Marg, Jaipur 302017

A Multinational Randomized Double Blind, Placebo-controlled study to evaluate the efficacy and safety of

2 Years Jaslok Hospital and Research Centre

A phase II study to determine the safety, efficacy, and pharmacokinetics of multiple intravenous

Years Tata Memorial Hospital

An Open, Prospective, Non-comparative, Multicenter Study to Estimate the recovery after a single infusion of


An Asia Pacific non-randomized, open-label phase II study evaluating the safety and efficacy of FOLFIRI plus cetuximab

4 Years Rajiv Gandhi Cancer Institute & Research

Centre

A Multicenter, Open-Label, Randomized, Phase II/III Study to Evaluate the Safety and Efficacy of

Phase 2/Phase 3

3 Years

A randomized open labeled parallel group phase III study of low-dose versus standard-dose granulocyte colony

2 Years

An Open Label, Multicenter Phase I/II Study Of Selective Cyclin Dependent Kinase Inhibitor P276-00 In

Phase 1/Phase 2

Months

204 3

100 5

Phase 1 8

40 Phase 1 2

450 Phase 3 9

100 Phase 3 5

24 Phase 1 3

100 Phase 2 4

25 Phase 1 6

93 4

A Phase 1b/2 Trial of AMG 479 or AMG 102 in Combination With Platinum-Based Chemotherapy as First-

Phase 1/Phase 2

Kidwai Memorial Institute of Oncology

Neo-Adjuvant Docetaxel plus Platinum for Locally Advanced Breast Cancer (LABC): A single arm Observational Study.

Not Applicable

1 Years Birla Cancer Center, SMS Medical College

Hospital

Phase 1b Single Arm, Open Label, Multi-Center Study of Fluphenazine HCl Monotherapy in Relapsed or Relapsed-

Years Tata Memorial Hospital

An open label, Phase I dose escalation clinical trial of NRC-AN-019 in patients with all phases of Chronic Myeloid

12 Months Department of Medical Oncology

A multicenter, multinational phase 3 randomized study to evaluate the safety and efficacy of treating

2 Years Site No. 0791, Bangalore Institute

of Oncology

Efficacy and safety of TULY (rasburicase) in prevention and treatment of malignancy-associated hyperuricemia - An open-

6 Months 2. MNJ Institute of Oncology and

Regional Cancer Center

A Multicentre Phase I Study Of Cremophor FreePaclitaxel Nanoparticle In Advanced Breast Cancer.

1 Years Kidwai Memorial Institute of Oncology

A Phase 2, Multi-Center, Open-Label, Randomized Study of Mapatumumab (TRM-1 [HGS1012], a Fully Human Monoclonal

4.5 Years Rajiv Gandhi Cancer Institute & Research

Centre

Phase 1 safety, efficacy, and pharmacokinetic study of Paclitaxel nano-dispersion injection in subjects with metastatic

12 Months Shatabdi Superspeciality

Hospital, Nashik

A Phase I/II Study of HKI-272 in Combination With Paclitaxel in Subjects With Advanced Solid Tumors and Breast

Phase 1/Phase 2

22 Months Maharashtra Medical

Foundation's (MMF) Joshi Hospital

120 Phase 3 13

8000 Phase 3 7

Phase 2 7

Phase 2 11

800 Phase 3 9

450 Phase 3 6

Phase 1 4

3000 Phase 3 7

70 Phase 1 2

20 1

A Prospective, Comparative, Randomized Multicenteric Phase III study to compare the

11 Months NRN Orthopaedic Clinic

EGF106708 : A Randomised, Multi-Centre, Open-Label, Phase III Study of Adjuvant Lapatinib,

All India Institute of Medical Sciences

A Phase 2, Randomized, Open-Label Study of Bosutinib Administered in Combination With Exemestane Versus

Months Tata Memorial Centre

A Multicenter, Open-Label, Randomized, Phase 2 Study to Evaluate the Efficacy and Safety of NKTR-102 (PEG-

Months Hemato-Oncology Clinic Ahmedabad

Pvt.Ltd.

A Phase 3b, Randomized, Open-Label Study of bevacizumab (AVASTIN®) + temsirolimus

48 Months SEAROC Cancer Centre

EGF106903 : Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study A

Ruby Hall Clinic-Cancer Centre

An open label, balanced, randomized, two period, two treatment, two sequence, and two way crossover study to

M S Patel Cancer Centre

EGF105485: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Study of Adjuvant Lapatinib

Ruby Hall Clinic-Cancer Centre

VEG105424 : An Open-Label, Pharmacokinetic Study of the Safety and Tolerability of Pazopanib in Combination With

NIMS,Medical Oncology Dept.

Optimizing the physical and biological parameters in craniospinal irradiation (CSI) for average risk

Phase 1/Phase 2

36 Months Advanced Centre for Treatment Research

and Education

20 1

1200 Phase 3 13

30 Phase 1 16

20 2

150 Phase 3 14

Phase 2 6

Phase 3 9

6 Jaslok Hospital

3000 Phase 3 20

122 Phase 2 4

Feasibility Study Evaluating Bladder Preservation By Helical Tomotherapy Based IMRT In Muscle Invasive

Not Applicable

2 Years Tata Memorial Centre

A Phase 3, Randomized, Open-Label, Two-Arm Study of Neratinib (HKI-272) Plus Paclitaxel Versus Trastuzumab Plus

Months Tata Memorial Hospital

A multicentre, randomized, open label, two-period, two-treatment, two-way crossover, bioequivalence

5 Months Curie Manvata Cancer centre, Opp.

Mahamarg Bus stand, Mumbai Naka, Nashik, A Phase I/II multicenter

study of IY5511HCI in Philadelphia chromosome positive chronic myeloid leukemia patients without

Phase 1/Phase 2

18 Months Dept. Of Medical Oncology, Prince Aly

Khan Hospital

A randomized, multi-center, open label study to evaluate the efficacy and safety of Peg G-CSF as compared to Grafeel® in

21 Months Amrita institute of medical sciences

Single-Arm, Open-Label, Multicenter Phase II Study to Evaluate the Efficacy and Safety of P276-00 in Patients With

Years Tata Memorial Hospital, Dr. E.

Borges Marg, Parel, Mumbai-400012

An International, Randomized, Double-Blinded, Phase 3 Efficacy Study of XL184 versus Placebo in Subjects with

Months All India Institute of Medical Sciences

A phase II/III Open label Multicentric Randomized trial to determine the safety and efficacy of Non-pegylated Liposomal

Part A:12, Phase 2/Phase 3

Two Years

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Long-term Safety and Efficacy of Darbepoetin

10 Years IRL Research Centre,

Phase 2 Study of HKI-272 in Subjects with Advanced Breast Cancer

3 Years Nizam's Institute of Medical Sciences

136 6

154 Phase 2 11

200 Phase 3 19

72 Phase 1 2

300 Phase 3 4

30 1

242 1

150 Phase 2 5

110 10

200 Phase 3 1

A Multicenter, Double-Blind, 3-Arm, Phase 1b/2 Study in Subjects With Unresectable Locally Advanced or Metastatic

Phase 1/Phase 2

4 Years Tata Memorial Hospital

A Phase I Followed by a Randomized, Phase II Study of Carboplatin and Etoposide with or without Obatoclax Administered

Months G Kuppuswamy Naidu Memorial

Hospital

A 24-week with possible extension, prospective, ulticentre, randomized, double blind, placebo-controlled, 2-parallel

30 Months Choithram Hospital and Research Centre

A Phase-I Clinical Study to Evaluate the Safety, Pharmacokinetics and Anti-Tumor Activity of NRC-AN-019 in Patients

1 Years Krishna Institute of Medical Sciences

A multinational, randomized, double-blind placebo controlled study of AVE8062 (25 mg/m²) administered every 3

3 Years FR. Muller Hospital Department of

Radiation Oncology

In vitro DNA damage assessment as predictor of response to chemotherapy in acute myeloid leukemia.

Not Applicable

2 Years Department of Pharmacology and

Department of Medical Oncology, AIIMS, New Delhi

A phase II / III, randomized, double-blind, placebo controlled study to investigate the efficacy of a probiotic

Phase 2/Phase 3

2 Years All India Institute of Medical Sciences

A Phase 2, Randomized, Double-blind, Placebo-controlled Study Evaluating the Safety and Efficacy of FOLFIRI in

4.5 Years Kidwai Memorial Institute of Oncology

A multicentre, randomized, open label, two-period, two-treatment, two-way crossover, bioequivalence

Not Applicable

06 Months Noble Hospital (Oncology

Department),153, Magar patta, City Road,Pune-411013

A randomized open labeled parallel group phase III study of antibiotics alone versus antibiotics plus

2 Years Tata Memorial Hospital

68 1

60 (India) Phase 3 9

59 Phase 2 1

2660 Phase 3 4

72 Phase 2 6

upto 45 Phase 2 2 Manipal Hospital,

A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab

Not Applicable

2 Years Department of Medical Oncology

A Randomized, Multicenter, Open-label, Phase 3 Study to Compare the Efficacy and Safety of Panitumumab

4 Years Kidwai Memorial Institute of Oncology,

Aspirin for Duke C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind,

18 Months Rajiv Gandhi Cancer Institute & Research

Centre

Aspirin for Duke C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind,

8 Years Department of Medical Oncology, Kidwai Memorial

Institute of Oncology, Hosur

An Open Label, Randomized, Multiple-Dose, Parallel Study To Evaluate The Safety And Efficacy Of Intravenous

17 Months IndoAmerican Cancer

Hospital,Road No. 14, Banjara Hills,

HyderabadA phase 2, open-label test-retest study to assess the reproducibility of quantitative measurements of 18F

24 Months

Site 2 Site 3 Site 4 Site 5

INHS Ashwini Hospital

Dinanath Mangeshkar hospital

Mahavir Cancer Hospital

O P Jindal Institute

Jaslok Hospital and Research Centre,

Dept. of Oncology, 15, Dr. G.

Rajiv Gandhi Cancer Institute and

Research Centre, Department of

Deenanath Mangeshkar Hospital and

Research Centre, Department of

Shatabdi Hospital

S. L. Raheja Hospital

Ruby Hall Clinic

Kidwai Memorial Institute of

Oncology, Bangalore

Medical College, Kozhikode

Apollo Hospital, Bangalore

Yashoda Hospital, Hyderabad

Dept. Of Surgical Oncology, CSM

Medical University, King george Medical University, Lucknow

Division of Head & Neck

Oncology,Regional cancer

Centre,Medical

Bhagwan Mahaveer Cancer Hospital &

Research Centre,Dept. Of

Medical

Bharath Hospital & Institute of

Oncology,Outer Ring Road,438 - Hebbal,

Mysore - 570017Jehangir Hospital, 32, Sassoon Road,

Pune 411001

Ruby Hall Clinic, New Cancer Bldg.,

3rd Floor, 40, Sassoon Road, Pune

411 001.

SEAROC Cancer Centre, S. K. Soni

Hospital, Sec-5 Vidhyadhar Nagar, Sikar Road, Jaipur

Tata Memorial Centre, Department of Medical Oncology,

Dr. Ernest Borges Road, Parel ,

Sri Ganga Ram Hospital


SEAROC Cancer Center

Jehangir Clinical Development Centre

Pvt. Ltd.

St. Johns Medical College & Hospital

King Edward Memorial Hospital

Sir Ganga Ram Hospital

Tata memorial hospital

All India Institute of Medical sciences


Shirdi Sai Baba Cancer Hospital

Katsurba Medical College & Hospital

Manipal

Apollo Cancer Institute

Bhagwan Mahawir Cancer Hospital & Research Centre

Government Medical College


Curie Manavata Cancer Center

S. K. Soni Hospital

3. NIMS Hospital

KEM Hospital, pune

Birla Cancer Centre

Tata Memorial Centre

Kashyap Nursing Home

Sparsh Hospitals and Critical care (p) ltd

Bhagwan Mahaveer Cancer Hospital & Research Centre

Mahaveer Cancer Sansthan

Netaji Subhash Chandra Bose

Cancer Research Institute

Indira Gandhi Institute of Medical

Sciences

Max Super Specialty Hospital


Department of Hematology, All India Institute of Medical Sciences

Site No. 0789, Tata Memorial Hospital,

Site No. 0787, Regional Cancer

Centre

Site No. 0792, Mahaveer Cancer

Sansthan

Site No. 0793, Jawaharlal Nehru

Cancer Hospital and Research Center

1. Bangalore Institute of Oncology

4. Indo-American Cancer Institute and

Research Center

5. King George Hospital, Andhra Medical College

Nizam's Institute of Medical Sciences

SEAROC Cancer Center


Bangalore Institute of Oncology

Bharath Hospital & Institute of Oncology

Manavata Curie Research centre

Kailash Cancer Hospital, Goraj

Apollo Hospital, Ahmedabad



Sushrut Hospital Yash Hospital

Jeevandip Hospital

shreeji Orthopedic and ENT Hospital

95/B,Siddhatek Appartments,

Central India Cancer Research Institute

Apollo Hospital Educational and

Research

Tata Memorial Hospital

NIMS, Department of Medical Oncology

SEAROC Cancer Centre

Jawaharlal Nehru Cancer Hospital & Research Centre


Private Limited

Kaushalya Medical Foundation Trust

Hospital

Chittaranjan National Cancer

Institue

Curie Manavata Cancer Centre

Kodlikeri Memorial Hospital

Rajalakshmi Multispeciality

Hospital

Apollo Speciality Hospital

Hemato-Oncology Clinic Ahmedabad

Pvt. Ltd



Private Limited



Apollo Hospital's Educational &

Research Foundation (Spectra Clinical

Research)

vCentral India Cancer Research

Institute

Mahavir Cancer Sansthan

Meeneakshi Mission Hospital and Rearch

Centre






Ruby Hall Clinic

Jehangir Hospital


Birla Cancer Centre, SMS Medical College

and Hospital

SEAROC Cancer Centre, S.K. Soni

Hospital



Hospital, Erandwane, Pune-

411004 Maharashtra

Ruby Hall Clinic 40 , sasoon Road, Pune-

411001

Meeneakshi Mission Hospital and Rearch Centre, Lake Area,

Melur Road, Madurai - 625107

PSG Institute of Medical Sciences &

Research,Off Avanashi Road,

Peelamedu,CoimbatoDepartment of

medical Oncology

Lakeshore Hospital & Research Centre

Ltd

Apollo Specialty Hospital

Indo American Cancer Institute and

Research Centre


Cancer Care Clinic and Hospital, 5th

floor, Vasant Sheela Tower, Lokmat

Square, Nagpur-

Institute Rotary Cancer Hospital, All

India Institute of Medical Sciences, New Delhi 110029

Malabar Institute of Medical Sciences, Govindapuram,

Calicut, Kerala- 16

St. Johns Medical College & Hospital,

Sarjapur Road, Bangalore 34


Hospital & Research Center


Hospital

Kidwai Memorial Institute Of Oncology

The Gujarat Cancer & Research Institute

Vedanta Institute of Medical Sciences

Dharamshila Hospital and

research centre

B.L. Kapur Memorial Hospital,


Jewaharlal Nehru Cancer Hospital and

Research Centre

Govt Medical College and Hospital

MNJ Institute of Oncology


Deenanath Mangeshkar Hospital and

Research Centre

Kothari Skin Centre

Apollo Hospitals

Shatabdi Hospital


Jawaharlal Nehru Cancer Hospital

Indo-American Cancer Institute & Research Centre


Acharaya Harihar Regional Cancer

Centre



Orchid Nursing Home

St. John's Medical College and Hospital

Deccan College of Medical Sciences

LTM medical college & LTM general

hospital

Nizams Institute of Medical Sciences

India Apollo Hospital, Education

& Research Foundation (Spectria Clinical Research),

Gokula Metropolis Clinical Research

Cente


MNJ Institute of Oncology

Jawaharlal Nehru Cancer Hospital and

Research Centre

Central India Cancer Research Centre, 11

Shankarnagar, Nagpur-440011,

India

Manvata Curie Cancer centre, Opp.

Mahamarg Bus stand, Mumbai Naka, Nashik,

Shatabdi Hospital, Suyojit City

Center,Mumbai Naka, Nashik,

Maharashtra-422005

Dr.Rai Memorial Medical Centre, No: 562 - Century Plaza, Teynampet,Chennai

- 600018

Shatabdi Hospital, Curie Manavata Cancer Centre,

MNJ Institute of oncology and

Research Cancer Centre,


Regional Cancer Centre


Dr. B.R.A Institute Rotary Cancer

Hospital, AIIMS, Ansari Nagar

Shalby Hospital, Opp. Karnavti Club,

S G High way, Ahmedabad

Moolchand Medcity, Main Ring Road,

Lajpatnagar III, New Delhi

CHL Apollo Hospital, Nr. L.I.G

Triangle, A.B. Road, Indore. M.P.

"Additional Professor, Breast

Cancer Clinic,Regional

Cancer Bangalore Institute

of Oncology,


Sanchetee Hosp & Cancer Inst

GKNM Hospital, GKNM Hospital,

Kidwai Hospital

Nizam's Institute of Medical Science,

Hyderabad

Jaslok Hospital,15,Dr.G.Deshmukh Marg,Peddar

Road,Mumbai-400026

Kashyap Nursing Home, Imperial

mahal, Dadar TT. Mumbai - 14

Curie Manavata Cancer Centre,

Dr Kamakshi Memorial Hospital



Meenakshi Mission Hospital & Research

Centre

Amrita Institute of Medical Sciences

M.S. Ramaiah Medical College and Teaching Hospital

Malabar Institute of Medical Sciences

Site No. 0784, Shatabdi Super

Specialty Hospital

Site No. 0786, SEAROC Cancer Center, S. K. Soni

hospital

Site No. 0785, Cancer Clinic, Shreevardhan

complex

Denananath Mangeshkar

Hospital, Pune

Aakar HospitalGandhi Orthopaedic Hospital

Jivani orthopedic, arthroscopy hospital

Princess Durru Shehwar Hospital



Regional Cancer Center


Dharamshila Hospital and

Research Centre

M.S. Ramaiah Memorial Hospitial

B.P. Poddar Hospital and Medical

Research Ltd.

Mehendi Nawaz Jung Institute of

Oncology and Regional Cancer

Centre


Bangalore Institute of Oncology

Lakeshore Hospital and Research Centre

Ltd.,

Regional Cancer Centre




Jehangir Hospital and Medical Centre

Jaslok Hospital Joshi Hospital

Ruby Hall Clinic


Meenakshi Mission Hospital and

Research Centre

B P Poddar and Medical Research

Ltd.

Shatabdi Super Speciality Hospital

Department of Radiotherapy,

Christian Medical College,IDA Scudder

Road,Vellore - 632


Cancer Research Institute, 16A, Park Lane, Kolkata-16

Dept. of Medical Oncology, M S Patel

Cancer Centre, Shree Krishna

Hospital, Gokal

Mahavir Cancer Sansthan, Phulwari

Sharif, Patna

Asian Institute of Oncology, S.L.

Raheja Hospital


Meenakshi mission hospital and research

centre



The Indo-American Cancer Institute & Research Centre



Sheth Nandlal Dhoot Hospital

Kaushalya Medical Foundation Trust

Hospital

Pravara Institute of Medical Sciences


Noble Hospital

178-Dh Sector Cancer Clinic

Amrita Institute of Medical Sciences & Research Centre,

Orchid Nursing Home


Dr. Kamakshi Memorial Hospital

Government Cancer Hospital

Smt. S. C. L. Hospital

Meeneakshi Mission Hospital,Melur

Road, Madurai - 625107

Cancer hospital & research institute,

Regional Centre for Cancer Research & Treatment, Cancer

Dept. of Medical Oncology, M S Patel

Cancer Centre, Shree Krishna

Hospital, Gokal

Mahavir Cancer Sansthan, Phulwari

Sharif, Patna

S. K. Soni HospitalRural Medical College, PIMS

Department of Medical Oncology,


Hospital

"Lions Cancer Detection Center,

New Civil Hospital, Majura Gate, Surat,

Gujarat.

Site 10

Orchid Nursing Home

IndoAmerican Cancer Institute & Research Center

Mahavir Cancer Sansthan

Indira Gandhi Institute of Medical Sciences

Dia Care Research Orthopaedic ClinicMadhu Orthopaedic Fracture & Accident Hospital,

Karne Hospitals Private Limited

Shatabti Superspeciality Hospital

Kaushalya Medical Foundation Trust Hospital

S. K. Soni Hospital,

Dayanand Medical College & Hospital

Institute Rotary Cancer Hospital, All India Institute of Medical Sciences

Deenanath Mangeshkar Hospital and Research Centre


M.D. Oswal Cancer Treatment & Research Foundation, G.T Road, Sherpur by

Jeevandeep Hospital, Station Road , Surat

Kaushalya Medical Foundation Trust Hospital.Thane (w)-400601

Hemato-Oncology Clinic, Vedanta Institute of Medical Science

Artemis Medicare Services Pvt Ltd


Orchid Nursing Home

Seth Nandlal Dhoot Hospital

A.H.Regional Cancer Center

LRS Instiute of TB & Respiratory diseases

B.J.Medical college New civil hospital

Hemato Oncology Clinic

Galaxy Cancer Institute

Sheth V. S. Hospital &. N. H. L- Municipal Medical College

Gandhi Medical College

Jeevandeep Hospital, 302, 3rd floor, Ayush Doctor House, Station Road, Surat

Jehangir Hospital

V.S. Hospitals Pvt. Ltd.

Chhatrapati Shauji Maharaj Medical University

SMS Medical College Hospital

Curi Manavata Cancer Centre

University College of Medical Sciences & GTB Hospital

Shri B.M.Patil Medical College

Amrita Institute of Medical Sciences and Research Centre

Govt. Medical College

Lakeshore Hospital & Research Centre Ltd

Shri Sidhivinayak Ganapati Cancer Hospital



S. no Trial CTRI No.and Date

1 trial 1

2 trial 2

3 Trial 3

4 Trial 4

5 Trail 5

6 Trial 6

7 Trial 7

8 Trial 8

9 Trial 9

UTRN.WHO

TEMP UTRN 123314078-31122008411821

CTRI/2008/091/000309, 16-01-2009

TEMP UTRN 093845302-09012009425431

CTRI/2009/091/000013, 01-12-2009

TEMP UTRN 052227973-28012009460856

CTRI/2009/091/000043, 13-10-2009

TEMP UTRN 123500298-11032009513970

CTRI/2009/091/000093, 01-07-2009

TEMP UTRN 110650739-2311200914682002

CTRI/2009/091/000976, 30-12-2009

TEMP UTRN 043939650-2611200914821953

CTRI/2009/091/000988, 08-12-2009

TEMP UTRN 112812871-29052009766602

CTRI/2009/091/000320, 17-06-2009

TEMP UTRN 104431905-070520096911045

CTRI/2009/091/000249, 15-09-2009

TEMP UTRN 054352547-180720091034856

CTRI/2009/091/000571, 13-01-2010

10 Trial 10

11 Trial 11

12 Trial 12

13 Trial 13

14 Trial 14

15 Trial 15

16 Trial 16

17 Trial 17

18 Trial 18

19 Trial 19

20 Trial 20

TEMP UTRN 121549629-1008200910981953

CTRI/2009/091/000633, 17-09-2009

TEMP UTRN 094148451-110820091102602

CTRI/2009/091/000636, 24-09-2009

TEMP UTRN 050650045-2808200911561804

CTRI/2009/091/000687, 17-11-2009

TEMP UTRN 063841923-10112009142427

CTRI/2009/091/000935, 24-02-2010

TEMP UTRN 114438089-3012200915861804

CTRI/2009/091/001085, 17-02-2010

TEMP UTRN 100748644-1901201016731444

CTRI/2010/091/000071, 16-02-2010

TEMP UTRN 064836834-0904201019671078

CTRI/2010/091/000348, 18-05-2010

TEMP UTRN 075744238-1604201020103408

CTRI/2010/091/000389, 04-06-2010

TEMP UTRN 115422816-1201201016461032

CTRI/2010/091/000046, 05-02-2010

TEMP UTRN 121831302-0503201018261444

CTRI/2010/091/000212, 22-06-2010

TEMP UTRN 043759194-2203201019002629

CTRI/2010/091/000282, 11-05-2010

21 Trial 21

22 Trial 22

23 Trial 23

24 Trial 24

25 Trial 25

26 Trial 26

27 Trial 27

28 Trial 28

29 Trial 29

30 Trial 30

31 Trial 31

TEMP UTRN 112127770-1705201021413503

CTRI/2010/091/000516, 08-07-2010

TEMP UTRN 123138764-24062009898599

CTRI/2009/091/000440, 27-07-2009

TEMP UTRN 112509752-10102008300599

CTRI/2008/091/000203, 01-01-2009

TEMP UTRN 122452186-10102008301599

CTRI/2008/091/000204, 11-02-2009

TEMP UTRN 110920818-21122008400346

CTRI/2008/091/000298, 27-05-2009

TEMP UTRN 052227973-28012009460856

CTRI/2009/091/000043, 13-10-2009

TEMP UTRN 123500298-11032009513970

CTRI/2009/091/000093, 01-07-2009

TEMP UTRN 112812871-29052009766602

CTRI/2009/091/000320, 17-06-2009

TEMP UTRN 100335508-03062009782602

CTRI/2009/091/000335, 17-06-2009

TEMP UTRN 012607951-070720099881728

CTRI/2009/091/000525, 11-08-2009

TEMP UTRN 043421444-25062009919602

CTRI/2009/091/000459, 06-08-2009

32 Trial 32

33 Trial 33

34 Trial 34

35 Trial 35

36 Trial 36

37 Trial 37

38 Trial 38

39 Trial 39

40 Trial 40

41 Trial 41

42 Trial 42

CTRI/2009/091/000681, 17-09-2009

CTRI/2009/091/000681, 17-09-2009

TEMP UTRN 033202200-0309200911821247

CTRI/2009/091/000713, 11-09-2009

TEMP UTRN 051827877-3009200912861009

CTRI/2009/091/000808, 11-12-2009

TEMP UTRN 063841923-10112009142427

CTRI/2009/091/000935, 24-02-2010

TEMP UTRN 041901423-020220101719602

CTRI/2010/091/000110, 15-04-2010

TEMP UTRN 041732350-0802201017432868

CTRI/2010/091/000132, 09-03-2010

TEMP UTRN 073931347-2704201020623444

CTRI/2010/091/000438, 19-05-2010

TEMP UTRN 031858125-30122008408741

CTRI/2008/091/000306, 05-02-2009

TEMP UTRN 040657729-200320095291096

CTRI/2009/091/000109, 10-06-2009

TEMP UTRN 023531053-1105201021203247

CTRI/2010/091/000495, 19-05-2010

TEMP UTRN 123314078-31122008411821

CTRI/2008/091/000309, 16-01-2009

43 Trial 43

44 Trial 44

45 Trial 45

46 Trial 46

47 Trial 47

48 Trial 48

49 Trial 49

50 Trial 50

51

52

53

TEMP UTRN 123314078-31122008411821

CTRI/2008/091/000309, 16-01-2009

TEMP UTRN 013302077-21102008310637

CTRI/2008/091/000213, 02-07-2009

TEMP UTRN 100727349-2807200910581889

CTRI/2009/091/000594, 11-08-2009

TEMP UTRN 020754308-080620097971475

CTRI/2009/091/000347, 08-07-2009

TEMP UTRN 104145110-200620098641475

CTRI/2009/091/000407, 06-07-2009

54

55

56

57

58

59

60

61

62

63

64

65

66

67

68

69

70

71

72

73

74

75

76

77

78

79

80

81

82

83

84

85

86

87

88

89

90

91

92

93

94

95

96

97

98

99

100

101

102

103

104

105

106

107

108

109

110

111

112

113

114

115

116

117

118

119

120

121

122

123

124

125

126

127

128

129

130

131

132

133

134

135

136

137

138

139

140

141

142

143

144

145

146

147

148

149

150

151

152

153

154

155

156

157

158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

191

192

193

194

195

196

197

198

199

200

201

202

203

204

205

206

207

208

209

210

211

212

213

214

215

216

217

218

219

220

221

222

223

224

225

226

227

228

229

230

231

232

233

234

235

236

237

238

239

240

241

242

243

244

245

246

247

248

249

250

251

252

253

254

255

256

257

258

259

260

261

262

263

264

265

266

267

268

269

270

271

272

273

274

275

276

277

278

279

280

281

282

283

284

285

286

287

288

289

290

291

292

293

294

295

296

297

298

299

300

301

302

303

304

305

306

307

308

309

310

311

312

313

314

315

316

317

318

319

320

321

322

323

324

325

326

327

328

329

330

331

332

333

334

335

336

337

338

339

340

341

342

343

344

345

346

347

348

349

350

351

352

353

354

355

356

357

358

359

360

361

362

363

364

365

366

367

368

369

370

371

372

373

374

375

376

377

378

379

380

381

382

383

384

385

386

387

388

389

390

391

392

393

394

395

396

397

398

399

400

401

402

403

404

405

406

407

408

409

410

411

412

413

414

415

416

417

418

419

420

421

422

423

424

425

426

427

428

429

430

431

432

433

434

435

436

437

438

439

440

441

442

443

444

445

446

447

448

449

450

451

452

453

454

455

456

457

458

459

460

461

462

463

464

465

466

467

468

469

470

471

472

473

474

475

476

477

478

479

480

481

482

483

484

485

486

487

488

489

490

491

492

493

494

495

496

497

498

499

500


Status of TrialWHO Last Verified on

Not yet recruiting

1/16/2009 1/16/2009 ACS

12/1/2009 7/7/2010 ACS

Open to recruitment

10/13/2009 6/25/2010 ACS

Terminated

7/1/2009 10/21/2009 ASC

Completed

12/30/2009 6/25/2010 ACS

Open to recruitment

12/8/2009 4/29/2010 ACS

Open to recruitment

6/17/2009 6/8/2010 ACS

Open to recruitment

9/15/2009 10/1/2009 ACS

Open to recruitment

1/13/2010 4/12/2010 ACS

Last Updated on Speciality-Subspeciality

Closed to recruitment follow up continuing & closed to recruitment

follow up complete fully

Open to recruitment

9/17/2009 11/20/2009 ACS

Open to recruitment

9/24/2009 11/12/2009 ACS

Open to recruitment

10/30/2009 17-11-1009 ACS

Open to recruitment

2/24/2010 2/16/2010 ACS

Open to recruitment

2/17/2010 02--4-2010 ACS

Open to recruitment

2/16/2010 5/11/2010 ACS

Open to recruitment

2/16/2010 7/6/2010 ACS

Open to recruitment

6/4/2010 6/1/2010 ACS

Open to recruitment

2/5/2010 7/12/2010 ACS

Open to recruitment

6/22/2010 6/25/2010 ACS

Open to recruitment

5/11/2010 5/11/2010 ACS

Open to recruitment

7/8/2010 7/8/2010 ACS

27-07-2009 23-07-2009 HF

Open to recruitment

1/1/2009 21-04-2010 HF

Open to recruitment 11/2/2009 11/2/2009

HF

Completed 5/27/2009 4/8/2010

HF


HF

Terminated 7/1/2009 10/21/2009

HF


HF


HF


HF


HF



HF


HF

12/11/2009 2/25/2010

HF


HF


HF


HF


HF

Completed 2/5/2009 3/30/2009

IHD

Completed 6/10/2009 6/25/2010

IHD


IHD

Not yet recruiting 1/16/2009 1/16/2009 Unstable Angina

Temporary halt or suspended

Not yet recruiting 1/16/2009 1/16/2009

Angina

7/2/2009 7/8/2009

8/11/2009 4/14/2010

7/8/2009 5/10/2010

7/6/2009 5/10/2010

Closed to recruitment of participants Coronary Artery

Disease


Disease


Disease



Public Title StudyWHO* Scientific Title of StudyWHO*

40

4000

300

NA

200

1264

220

T. sample size

A study to assess the safety and efficacy of Fondaparinux in unstable angina and non-ST elevation myocardial infarction compared to historical controls

A prospective, single arm, open trial to assess the safety and efficacy of Fondaparinux in patients with unstable angina and non-ST elevation myocardial infarction compared to

AR1108888 : FondaparinUx Trial with UFH during Revascularization in Acute Coronary Syndromes (FUTURA/OASIS 8)

FondaparinUx Trial with UFH during Revascularization in AR1108888: Acute Coronary Syndromes (FUTURA) A prospective study evaluating the safety of two

A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes

Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1 ≥ 6.5% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or

A Clinical Trial to Assess The Effects of a Drug, BG9928, given intravenously, in Subjects With Acute Decompensated Heart Failure (ADHF) and Reduced A clinical trial to study the effects of drug, Prasugrel in patients with acute coronary syndrome.

"A DOUBLE BLIND, RANDOMIZED, MULTICENTRIC, PHASE-III TRIAL TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF TABLET

Study Evaluating Safety, Tolerability and Efficacy of YM150 in Subjects with Acute Coronary Syndromes

A Randomized, Double-Blind, Placebo Controlled Multi- Center and Parallel Group Study of the Safety, Tolerability and Efficacy of YM150 in combination with Standard

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-Mortality in Patients With Chronic Heart Failure (ATMOSPHERE)

A Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril

A Clinical Trial to Evaluate the Safety and Efficacy of Apixaban In Subjects with a Recent Acute Coronary Syndrome

A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects with a Recent Acute Coronary Syndrome

A clinical trial to study the effects of two drugs, prasugrel and clopidogrel in patients with acute coronary syndrome who are to undergo percutaneous

A prospective, randomised, double-blind, double dummy, comparative, parallel assignment, multicentric clinical trial to compare the safety and efficacy of Prasugrel vs.

50

240

500

30

5400

11500

140

A study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects with atrial fibrillation.

A Phase 2, Double-Blind, Double-Dummy, Randomized, Parallel Group Dose Finding Study To Investigate the Safety and Tolerability of YM150 in Subjects with Non-Valvular Atrial

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated

A study of the clinical experience with atorvastatin 80 mg in patients with acute coronary syndromes (heart attack )

Post-marketing study of clinical experience of Lipicure 80® (atorvastatin 80 mg) in patients with acute coronary syndromes Acronym: Cure - ACS

A clinical trial to study the effect of standard treatment of heart failure on plasma levels of Apelin in patients with heart failure.

Effect of Therapy on Plasma Apelin Levels in Patients of Heart Failure.

CLINICAL TRIAL FOR EVALUATION OF EFFICACY AND SAFETY OF PRASUGREL IN COMPARISON WITH

AN OPEN LABEL, RANDOMIZED, PARALLEL GROUP, PROSPECTIVE, MULTICENTRE CLINICAL TRIAL FOR EVALUATION OF EFFICACY

A Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With Insulin Glargine.

A Randomized, Open-Label, Active-Controlled, Parallel-Group, Multicenter Study to Determine the Safety and Efficacy of Albiglutide Administered in Combination With

A Study of Acute Coronary Syndrome Patients

A Comparison of Platelet Inhibition Following a Prasugrel 60 mg or Prasugrel 30 mg Loading Dose With or Without Pretreatment With a Clopidogrel Loading Dose in Acute

A STUDY TO EVALUATE THE EFFECT OF EDIBLE OIL IN PATIENTS OF TYPE II DIABETES MELLITUS & HYPERTENSION.

A STUDY TO EVALUATE THE EFFECT OF EDIBLE OIL (RBS8020) IN PATIENTS OF TYPE II DIABETES MELLITUS & HYPERTENSION

Cardiovascular Outcomes Study of Alogliptin in Subjects With Type 2 Diabetes and Acute Coronary Syndrome (EXAMINE)

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in

The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial (SOLID-TIMI 52)

A Clinical Outcomes Study of Darapladib versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular

A Phase IIa, Randomized, Single-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 28-day Repeat

GSK PHI112844: A Phase IIa, Randomized, Single-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of 28-

600

2300

800-1000

2000

28

300

124

A clinical trial to study reduction of cardiovascular mortality and morbidity in Type 2 diabetes mellitus patients with a recent Acutecoronarysyndrome event

Cardiovascular outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients with a recent acute coronary syndrome (ACS) event and type 2

DOT-HF Trial - International trial to determine the diagnostic outcome in Heart Failure

DOT.HF Diagnostic Outcome Trial in Heart Failure

South Asian Systolic Heart Failure Registry (SASHFR) : Registry to understand benefits of implantable device therapy known as cardiac

SASHFR (South Asian Systolic Heart Failure Registry) : A multi-center, nonrandomized, prospective study to collect data pertaining to the demographic and cardiovascular

PANARM HF : A clinical registry to understand the disease profiles of patients who suffer from cardiac arrhythmias and/or heart failure and to understand the diagnosis

PANARM HF -A prospective, multi-center, non-interventional to collect (at the referring physician stage), data pertaining to the demographic, cardiovascular and disease etiology

Cardiac rehabilitation and quality of life in congestive heart failure

The effects of exercise based cardiac rehabilitation on quality of life in congestive heart failure

A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes mellitus

Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1 ≥ 6.5% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or

A Clinical Trial to Assess The Effects of a Drug, BG9928, given intravenously, in Subjects With Acute Decompensated Heart Failure (ADHF) and Reduced

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess The Effects of Intravenous BG9928 on Body Weight in Subjects with Acute

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbi-Mortality in Patients With Chronic Heart Failure (ATMOSPHERE)

A Multicenter, Randomized, Double-Blind, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Both Aliskiren Monotherapy and Aliskiren/Enalapril

Effect of Vildagliptin on Left Ventricular Function in Patients With Type 2 Diabetes and Congestive Heart Failure

A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Effect of 52 Weeks Treatment With Vildagliptin on Left Ventricular

A clinical trial to study the effects of propranolol (a beta blocking drug) in children with ventricular septal defect and heart failure

Ventricular Septal Defect - Propranolol for Heart Failure (VSD-PHF Study)

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart

A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the 6 Months Efficacy and Safety of Aliskiren Therapy on Top of

290

40

200

50

7980

11330

102

10

40

LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-Ventricular Ejection Fraction

A Thirty Six-Week, Randomized, Double-Blind, Multi-Center, Parallel Group, Active Controlled Study to Evaluate the Efficacy, Safety and Tolerability of LCZ696 Compared to

A clinical study to evaluate performance of a non-invasive study device to monitor patients fluid status in congestive heart failure.

Adherent Monitoring of Congestive Heart Failure during Therapy for Excess Fluid (ACUTE) Study

A comparative evaluation of efficacy, safety & tolerability of Carvedilol Phosphate Extended Release Capsules 80 mg (Test Drug), with Carvedilol Phosphate

A comparative, single blind, parallel group, non-crossover, multi-centric trial of Carvedilol Phosphate Extended Release Capsules 80 mg (Test Drug), with Carvedilol

A clinical trial to study the effect of standard treatment of heart failure on plasma levels of Apelin in patients with heart failure.

Effect of Therapy on Plasma Apelin Levels in Patients of Heart Failure.

This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart

A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity

A clinical trial with ivabradine in patients with stable coronary artery disease

Effects of ivabradine in patients with stable coronary artery disease without clinical heart failure. A randomised double-blind placebo-controlled international multicentre

A clinical trial to study the efficacy and safety of metoprolol in heart failure with normal ejection fraction

Evaluation of efficacy and safety of metoprolol in patients having heart failure with normal ejection fraction: a Randomised, Double-Blind, Placebo-Controlled Trial

A clinical trial comparing bronchodilator effects of two drugs,Tiotropium Bromide and Formoterol Fumarate each over 24 hours in subjects with Asthma.

A Randomized, double-blind, crossover, non-inferiority study comparing bronchodilator effects of single dose of 18 mcgg of Tiotropium Bromide and two doses of 12 mcg of

A study evaluating the therapeutic potential of low dose Roxithromycin therapy in patients of stable bronchial asthma.

A study evaluating the therapeutic potential of low dose Roxithromycin therapy in patients of stable bronchial asthma.

A clinical trial to study the lung deposition of a pressurized metered dose inhaler (pMDI)in patients with COPD and Asthma

A gamma scintigraphy study to determine the lung deposition of inhaled aerosolized radiolabeled budesonide/formoterol(200/6mcg)in patients with COPD and Asthma



40

100

360

3000



XIENCE V India: XIENCE V Everolimus Eluting Coronary Stent System (EECSS) India Post-Marketing Registry

XIENCE V Everolimus Eluting Coronary Stent System (EECSS) India Post-Marketing Registry

Intek Apollo Paclitaxel Eluting coronary stent study

Clinical success and safety of Intek Apollo coronary drug eluting stent with paclitaxel release in patients with de novo lesion

Series III Run-In Trial: Random comparison of Supralimus(R) with Xience V(TM) in the treatment of patients suffering from new congenital atherosclerosis of

Series III Run-In Trial: A randomized comparison of the Supralimus(R) stent with the Xience V(TM) stent in the treatment of patients with de novo native coronary E-SERIES Registry: Supralimus(R) and

Supralimus-Core(TM) Cardiac Stents for the Treatment of Coronary Artery Blockage.

E-SERIES Registry: A Prospective and Retrospective, Multinational Investigation of the Supralimus(R) and Supralimus-Core(TM) Sirolimus-Eluting Stents for the Treatment of Unselected Patients with Coronary Lesions in the Real-World Clinical


Phase Site 1

Phase 3 1

14 Banker's Heart Institute

Phase 2 6

Phase 3 NA 11

Phase 3 4

Phase 2 16 The Heart Care Clinic

Phase 3 24 PRS Hospital

Phase 3 Years 30

Phase 3 14

Esti trial duration

total Sites no

3 Months Department of cardiology, CMC hospital

Phase 3/Phase 4

2 Years Spandan Heart Institute and Research Center

SAL Hospital & Medical Institute

5 Months Cooper Hospital,

Vileparle(W), Mumbai, [email protected]

21 Months

Tagore Heart Care and Research Centre,

12 Months G. B. Pant Hospital & Maulana Azad Medial

College

Phase 2 Months 15

12

Phase 4 9

2

Phase 3 12

Phase 3 12 ACEER

5

Phase 3 1 IRL Research Centre

Phase 3 40 KEM Hospital

Phase 3 27

Phase 2 7 BYL Nair Hospitak


Centre

Phase 2/Phase 3


Months Escorts Heart Institute and Medical Research

Center

Not Applicable

2 Years Room No. 4046D,

Department of Pharmacology, A.I.I.M.S.

B.M. Birla Heart Research Centre

35 Months

Narayana Hrudayalaya Institute of Medicine

5 Months

4.75 Years

5 Years Nizam's Institute of Medical Sciences

12 Months

Phase 3 40 Care hospitals

3 Dr. Ajay Naik

Phase 4 11 The Heart Care Clinic

8

C-4/3 Vasant Vihar

1

Phase 2 6

Phase 3 11

Phase 3 24

Phase 4 11

1 AIIMS

Phase 3 18

4 Years

Phase 3/Phase 4

5 Years

5.5 Years

Not Applicable

2 Years

Not Applicable

1 Years Department of physiotherapy


Years SAL Hospital & Medical Institute

Years Metro Multispeciality Hospital

Months FORTIS FLT. LT. RAJAN DHALL HOSPITAL

Phase 3/Phase 4

2 Years

MGM Medical College & M.Y Hospital

Phase 2 9

1

Phase 3 2

2

Phase 3 30

Phase 3 9

Phase 2 1 PGIMER

Phase 3 1

Phase 4 1

Phase 4 1

Phase 3 1

1 Years S. R. Kalla Memorial Gastro & General Hospital

Not Applicable

12 Months Escorts Heart Institute and Research Center, Okhla Road, New Delhi (India)-110 025

3 Months Apex Superspeciality Hospital

Not Applicable

2 Years Room No. 4046D, Department of Pharmacology, A.I.I.M.S.

43 Months Choithram Hospital & Research Centre

2.5-5 Years Escorts Heart Institute and Research Centre

2 Years

1 Years Chest Research Foundation

Months Chest Research Foundation

45 Days Institute of Nuclear Medicine & Allied Sciences (INMAS)


Phase 3 1

Phase 4 18

Phase 3 6

Phase 4 15 PRS Hospital

Phase 4 1


Years Escorts Heart Institute & Research Centre

1 Years Meenakshi Mission Hospital & Research Centre

Years

2 Years Shri B.D. Mehta Mahavir Heart Institute


Site 2 Site 3 Site 4

Heart & General Hospital

CARE Hospital Shri Ram Cardiac Center

Prime Hospital

PGI

Avanti Institute of Cardiology

Spandan Heart Institute & Research Centre


narayana Hrudayalaya Institute of Medical

Sciences

5th Floor, Sir Ganga Ram Hospital

Institute of Cardiovascular Diseases

Clinic ,Bhavnagar,[email protected]

K.E.M.Hospital & Seth G.S. Medical

College,Mumbai,[email protected]

Smt. N H L Muni. Medical College,Ahmedabad,Rajp

[email protected]

Department of Cardiology, Life Care Institute of Medical Science and

Research

Total CardioVascular Solutions Pvt. Ltd

Metro Multispeciality Hospital

Meenakshi Mission Hospital and Research

Centre

Dharma Vira Heart Centre

S.R.Kalla Memorial Gastro & General

Hospital

Shri Krishna Hrudayalaya & Critical Care Centre

Cardiac Care & Counseling Center

M S Ramaiah Narayana Hrudalaya,

Wockhardt Heart Hospitals

Grant Medical Foundation CARE Hospital

Ruby Hall Clinic Fortis Hospital

Care Hospital

Sterling Hospital

Osmania General Hospital King George Hospital

Bollineni Ramanaiah Memorial Hospital (P)

Limited

Meenakshi Mission Hospital & Research

Centre

Healing Touch Angiography & Cardiac Surgery Centre, Gupte

Cardiac Care Centre and Hospital

Bangalore Diabetes Hospital

Madras Diabetes Research Foundation

Health and Research Centre

Life Care Institute of Medical Science & Research Centre

Cardiology OPD, Department of Cardiology,

Life Care Institute of Medical Science & Research Centre


Medisys Clinisearch India Pvt Ltd

Kasturba Medical College Hospital

Christian Medical College and Hospital

All India Institute of Medicine

Escorts Heart Institute and Research Centre

Shatabdi Superspeciality Hospital

Department of Medicine, M.G.M. Medical College

and M.Y. Hospital,


Center, Dept. of Cardiology

Institute of Cardiovascular Diseases,

Pondicherry Inst of Medical Sciences

Mediciti Hospital Medwin Hospitals

TCVS

CARE Hospital Madras Medical Mission

Heart Care Clinic


CARE Hospital Shri Ram Cardiac Center

Kasturba Hospital

Deenanath Mangeshkar Hospital

Escorts Heart Institute & Research Centre

Escorts Heart Institute & Research Center

Escort Heart & Research Institute


narayana Hrudayalaya Institute of Medical Sciences

5th Floor, Sir Ganga Ram Hospital


Meenakshi Mission Hospital and Research Centre


DAYANAND MEDICAL COLLEGE AND HOSPITAL

S.R. KALLA MEMORIAL HOSPITAL

KING GEORGE HOSPITAL ANDHRA MEDICAL COLLEGE

St. John's Medical College Hospital

G Kuppuswamy Naidu Memorial Hospital

Narayana Hrudayalaya Institute of Medical Sciences

Mediciti Hospitals,

Bankers Heart Institute Care Hospital

TCVS Pvt Ltd Spandan Heart Institute


Monilek Hospital & Research Centre

Shree Venkatesh Hospital and Polyclinic

Cardiology OPD, Department of Cardiology,

Health And Research Center

Life Care Institute of Medical Science and Research

Madras Medical Mission Holy Family Hospital Krishna Heart Institute

Madras Medical Mission Wockhardt Heart Hospital

Apollo Hospital Madras Medical Mission

Life Care Institute of Medical Sciences & Research Centre

Shri.Jayadeva Institute of Cardiology



Sir Ganga Ram Hospital,

CARE Hopsitals

Kasturba Hospital Mediciti Hospitals

The Heart Care Clinic Sir Ganga Ram Hospital

Sanjay Gandhi Post Graduate Institute Of

Medical Sciences

Max Devki Devi Heart and Vascular Institute,

Deenanath Mangeshkar Hospital and Research

Centre


Christian medical College and Hospital

Delhi Heart and Lung Institute

WestFort Hi-Tech Hospital Ltd

A. J. Hospital and Research Centre



M.S Ramaih Memorial Hospital

Life Care Institute of Medical Sciences &

Research,

Kovai Medical Centre & Hospital Limited,

Grant Medical Foundation, Ruby Hall

Clinic,

Yasoda Hospital Sanjay Gandhi PGIMS

Hridayam Heart Care V.S. General Hospital

Sir Ganga Ram Hospital

Bhatia Hospital

Bankers Heart Institute

Manipal Hospital

M. S. Ramaiah Memorial Hospital

Jnana Sanjeevini Medical Center

Nizam?s institute of Medical Sciences

Pitale Diabetes & Hormone centre

Department of Cardiology, PRS Hospital

B.M. Birla Heart Research Centre

Kokilaben Dhirubhai Ambani Hospital

Shree Saibaba Heart Institute & Research

Centre


Gokula Metropolis Clinical Research Center

Manipal AcuNova KH Clinical Research Center,

Lifecare Institute of Medical Sciences and

Research

Dande Diabetes and Heart Care Centre

Fortis Escorts Hospital, (A Unit of Escorts Heart and Super Specialty Limited)


Rangdore Memorial Hospital

MAMC - Lok Nayak Hospital

Glenmark Cardiac Center Frontier Lifeline

Fortis Hospital, Mohali

Escorts Hospital

Mediciti Hospitals

Omega Hospital

KLES Dr.Prabhakar KORE hospital

Gandhi's Research Institute

Instride Hospital & research centre

Indraprastha Apollo Hospital

Escorts Hospital & Research Center



Christian medical College and Hospital

Delhi Heart and Lung Institute

WestFort Hi-Tech Hospital Ltd



HEALTH AND RESEARCH CENTRE

LIFE CARE INSTITUTE OF MEDICAL SCIENCE & RESEARCH

PITALE DIABETES & HORMONE CENTRE


Escorts Heart Institute and Research Centre

Kasturba Hospital Wockhardt Heart Hospital

Mediciti Hospital Omega Hospital

Ruby Hall Clinic PSG Hospitals Holy Family Hospital

Crescent Hospital & Heart Centre

Shri Krishna Hrudayalaya & Critical Care Centre

Lissie Hospital

Zynova Heart Hospital

Life Care Institute KEM Hospital

Poona Hospital And Research Centre

SAL Hospital And Medical Institute

Grant Medical Foundation, Ruby Hall Clinic

Jaslok Hospital & Research Centre



Holy Family Hospital

S.P. Medical College

Nanjappa Hospital


St. Johns Medical College & Hospital

Poona Hospital & Research Centre


MGM Medical College and MY Hospital


Cresent Hospital and Heart Centre


S. R. Kalla Memorial Gastro & General

Hospital

Baroda Heart Institute & Research Centre

M.V. Hospital and Research Center

SP Medical College & AG Hospitals,

KEM Hospital & Seth GS Medical College,

Dr. Ramesh Cardiac and Multispeciality Hospital

Ltd.,

Institute of Post Graduate Medical Education &

Research,

Apollo Gleneagles

Fortis Hospital Apollo Hospital

V.S. General Hospital Sterling Hospital

KEM Hospital

Ruby Hall Clinic CARE Hospital

CRESCENT HOSPITAL


Bhagwan Mahaveer Jain Hear Centre

Samatvam: Endocrinology Diabetes Centre

S.R Kalla Memorial Hospital

Gokula Metropolis Clinical Research Centre

Kamalnayan Bajaj Hospital

Diabetes Care and Research Centre,

CARE Foundation, CARE Hospital

ShreeKrishna Hospital and Heart care centre

Deenanath Mangeshkar Hospital and Research

Centre

Maulana Azad Medical College and Guru Nanak

Eye Centre

Gurunanak CARE Hospital

KEM Hospitals Belgaum Diabetes Centre

Fortis Hospital Medanta- The Medicity Asian Heart Institute

Indraprastha Apollo Hosp

S.P. Medical College


Bankers Heart Institute,

Bankers Heart Institute Arneja Heart Institute



MGM Medical College and MY Hospital

S. R. Kalla Memorial Gastro & General Hospital

Indraprastha Apollo Hospitals



Crescent Hospital & Heart Centre

Osmania Medical College

Bisne Heart Hospital Ruby Hall Clinic

Artemis Health Institute

L.T.M.M College & Hospital

Sri Gokulam Medical College & Research Foundation

Max Devki Devi Heart and Vascular Institute

Apollo Hospital Christian Medical College

Ruby Hall Clinic


B.M.Birla Heart Research Center




Sterling Hospital,

CRESCENT HOSPITAL

TCVS Pvt. Ltd Heart & General Hospital Apollo Hospitals

Care Hospital,

Krishna Heart & Super Specialty Institute


3-MM II, Panchkuian Road

Sri Venkateswara Institute of Medical Sciences

J.S.S. Hospital and Medical College

Sangini Hospital, Neonatal, Padiatric &

Adult Intensive Care Units

Indraprastha Apollo Hospitals


Apollo Gleneagles Hospitals Ltd

All India Institute of Medical Sciences,

King George Hospital

Sterling Hospital

Care Hospital Bankers Heart Institute

The Heart Care Clinic Fortis Hospital Mediciti Hospitals

Poona Medical Research Foundation

Krishna Heart & Superspeciality Institute

St. John's Medical College Dept. of cardiology

Diabetes Thyroid Hormone Research

Institute


Dande Diabetes & Heart Care Centre, Maternity &

Nursing Home,

M.V.Hospital for diabetes and Diabetic Research

Centre

St. Johns Medical College and Hospital

KMC Hospital St Johns Medical College


CRESCENT HOSPITAL

Omega Hospital

KEM Hospital

Bangalore Endocrinology and Diabetes Research

centre

Deenanath Mangeshkar Hospital & Research Centre


SHRIKRISHNA HRUDAYALAYA AND CRITICAL CARE

Poona Hospital and Research Centre


Nimit Matra HospitalHeart First Cardiac and Vascular Clinic

Shree Sai Baba Heart Institute and Research Center

Fortis HospitalEscorts Heart & Superspeciality Institute Ltd.

Max Devki Devi Heart & Vascular Institute

Kailash Health Care Limited

Sanjay Gandhi Post Graduate Institute of Medical Sciences

Max Devki Devi Heart and Vascular Institute



The Heart Care Institute,

Radiance Hospital Arneja Heart Institute

Care Hospital,

Aditya Hospital & Critical Care Unit

SHRIKRISHNA HRUDAYALAYA AND

CRITICAL CARE

ARNEJA HEART INSTITUTE,

BISNE HOSPITAL PVT LTD

Monilek Hospital And Research Centre

Deenanath Mangeshkar Hospital and research

center,

Grant Medical Foundation, Ruby Hall Clinic, 40, Sasoon Road,

Pune - 411001

Heart Care Clinic Narayana Hrudayalaya

Sir Ganga Ram Hospital Omega Hospital Pvt. Ltd.

Fortis Escorts Hopsital

Meenakshi Mission Hospital and Research

Centre

Apollo Hospitals International Ltd

Dept. of Cardiology, Dharma Vira Heart

Centre,

JSS Hospital Ruby Hall Clinic

Mediciti Hospitals Frontier Lifeline Pvt Ltd

Poona Hospital and Res Centre

ARNEJA HEART INSTITUTE,

BISNE HOSPITAL PVT LTD

AVANTI INSTITUTE OF CARDIOLOGY PVT. LTD


Metro Multispeciality Hospital

Dharam Vira Heart Centre

Bhanubhai & Madhuben Patel Cardiac Centre

Jehangir Hospital CARE Hospital Heart & General Hospital





RUBY HALL CLINIC K.E.M HOSPITAL,AVANTI INSTITUTE OF

CARDIOLOGY PVT. LTD

Lifecare Institute of Medical Sciences &

Research,

Escorts Heart Institute and Research Center,

Okhla Road, New Delhi - 110025

"Patiala Heart Institute, 2- Jagdish Marg, Patiala-147

001 (Punjab) India

Osmania Medical College

Sterling Hospital

Dayanand Medical College and Hospital

S R Kalla Memorial Gastro and General

Hospital

Cardiology Department, Sadbhavna Medical &

Heart Institute

Krishna Institute of Medical Sciences,

BGS Global Hospital

RUBY HALL CLINIC K.E.M HOSPITAL,

Lakeshore Hospital and Res Ctr

Narayana Hrudayalaya Institute of medical

sciences

DEENANATH MANGESHKAR HOSPITAL & RESEARCH CENTRE

Sri Jayadeva Institue of Cardiology

Kovai Medical Center and Hospital Limited

Deep Heat CentreBhanubhai & Madhuben Patel Cardiac Centre

Choithram Hospital & Research Centre



DEENANATH MANGESHKAR

HOSPITAL & RESEARCH CENTRE

NARAYANA HRUDAYALAYA INSTITUTE OF

MEDICAL SCIENCES

KOVAI MEDICAL CENTER AND

HOSPITAL LIMITED

Vikram Hospital & Heart Care, #46, Vivekananda

Road, Yadavagiri, Mysore-570020 Karnataka

G. Kuppuswamy Naidu Memorial Hospital,

Narayana Hrudayalaya, 258/A- Bommasandra

Industrial Area, Anekal Taluk, Bangalore-560 099

Karnataka

Kovai Medical Centre

Apollo Hospitals Fortis Hospital,

Christian Medical College and Hospital

West Fort Hi-tech Hospital

Medanta -The Medicity, Medanta Heart Institute,

Asian Heart Institute

Yashoda Hospital

Global hospital & health city

Jnana Sanjeevini Med Centre

NARAYANA HRUDAYALAYA INSTITUTE OF MEDICAL SCIENCES

KOVAI MEDICAL CENTER AND HOSPITAL LIMITED

JSS Medical College Kalcadiya HospitalLife Care institiute of Medical Science &Research


Site 22 site 23 Site 24

Yashoda Hospital Sanjivani Super Speciality Hostpital,

Holy Family Hospital, St. Andrew's Road, Bandra (West) Mumbai-400050

Maharashtra

Nanjappa Hospital, 660, Kuvempu Road, Shimoga-

577201 Karnataka

Mediciti Hospitals, 5-9-22, Secretriat Road,

Hyderabad- 500063 Andhra Pradesh

Holy Family Hospital Yashoda group of HospitalRamesh Cardiac and

Multi Speciality Hospital Ltd.

Fortis Flt. Lt. Rajan Dhall Hospital

Sanjay Gandhi Postgraduate Institute of

Medical Sciences

CARE Hospital (Visakha Hospitals & Diagnostics Ltd.) A.S. Raja Complex

PRS Hospital

Amrita Institute of Med Sci

MSRamaiah Narayana Hurdyalaya

Mahavir Hospital and Research Centre

Sanjivani Super Speciality Hostpital,

Indus Hospital JSS Medical College Fortis Malar Hospital



Dr Ramesh Cardiac & Multispeciality Hosp. Ltd.,

Fortis Escorts HospitalJLN Marg,

Malviya NagarJaipur-302 017Rajasthan

Avanti Institute of Cardiology, 5- Abhyankar Road, Dhantoli, Nagpur-

440012 Maharashtra

Care Hospital Mediciti HospitalNarayanan Hrudayalaya

Institute of Medical Sciences

Fortis Escorts Hospital and Research Centre

Lotus diagnostic Centre Artemis Health InstituteLife Care Institute of Medical Sciences

Osmania Medical College Wockhardt Heart HospitalLittle Flower Hospital And Research Centre



Shri Sai Baba Heart Institute & Research

Centre,

"Hope Specialty Hospital, 200- W K Road, Meerut ?

250001 Uttar Pradesh, India.

P R S Hospital Frontier Lifeline HospitalP S Medical College and Shree Krishna Hospital

The Heart Care Clinic Yashoda Super Speciality Hospitals


St. Isabels HospitalVijan Cardiac & Critical Care Centre

Medwin Hospitals Tagore Heart Care and Research Centre

Shree Saibaba Heart Institute and Research

Centre

Endocrinology Diabetes Center

Inst of Post Grad Med Ed Res

City Diagnostics WE-LINK SMO


CTRI No.and Date

Trial 1 11/18/2008

Trial 2 8/22/2008

Trial 3 1/25/2008

Trial 4 Completed 3/27/2008

Trial 5 4/24/2008

Trial 6 4/30/2008

Trial 7 4/30/2008

Trial 8 6/30/2008

Trial No.

UTRN.WHO Status of TrialWHO

Last Verified on

TEMP UTRN 050440745-11112008346614

CTRI/2008/091/000248, 18-11-2008


TEMP UTRN 041851255-0201200863215

CTRI/2008/091/000001, 22-08-2008

Open to recruitment

TEMP UTRN 020846127-2001200876203

CTRI/2008/091/000010, 25-01-2008

Not yet recruiting

TEMP UTRN 051429058-3101200880234

CTRI/2008/091/000014, 27-03-2008

TEMP UTRN 024151995-11042008115187

CTRI/2008/091/000040, 24-04-2008

Open to recruitment

TEMP UTRN 111501559-22042008122327

CTRI/2008/091/000047, 30-04-2008

Not yet recruiting

TEMP UTRN 033022512-25042008129327

CTRI/2008/091/000054, 30-04-2008

Not yet recruiting

TEMP UTRN 080401529-23052008146368

CTRI/2008/091/000070, 30-06-2008



Trial 10 6/9/2008

Trial 11 6/19/2008



Trial 14 9/25/2008

Trial 15 11/3/2008

Trial 16 9/11/2009

TEMP UTRN 024223858-26052008147187

CTRI/2008/091/000071, 15-07-2008

TEMP UTRN 105621713-28052008150129

CTRI/2008/091/000074, 09-06-2008

Open to recruitment

TEMP UTRN 114513161-09062008173164

CTRI/2008/091/000087, 19-06-2008

Open to recruitment

TEMP UTRN 115010744-30062008188406

CTRI/2008/091/000099, 21-07-2008

TEMP UTRN 040444495-10072008203420

CTRI/2008/091/000112, 05-11-2008

TEMP UTRN 120312396-21092008274557

CTRI/2008/091/000179, 25-09-2008

Open to recruitment

TEMP UTRN 102550127-1609200826427

CTRI/2008/091/000169, 03-11-2008


TEMP UTRN 070651232-2909200828648

CTRI/2008/091/000191, 11-09-2009

Open to recruitment


Trial 18 11/17/2008


Trial 20 Terminated 11/28/2008

Trial 21 12/12/2008





TEMP UTRN 122846831-08102008298602

CTRI/2008/091/000201, 16-06-2009

TEMP UTRN 103511148-13102008303620

CTRI/2008/091/000206, 17-11-2008

Open to recruitment

TEMP UTRN 113712877-29102008323509

CTRI/2008/091/000226, 12-01-2009

TEMP UTRN 024937708-19112008352605

CTRI/2008/091/000254, 28-11-2008

TEMP UTRN 115109450-08122008374753

CTRI/2008/091/000276, 12-12-2008


TEMP UTRN 111643947-15122008386609

CTRI/2008/091/000286, 28-01-2010

TEMP UTRN 110159200-19122008397753

CTRI/2008/091/000295, 22-12-2008

TEMP UTRN 124557766-19122008398753

CTRI/2008/091/000296, 22-12-2008

TEMP UTRN 024511826-07012009424529

CTRI/2009/091/000012, 03-02-2009


Trial 27 10/13/2009



Trial 30 3/4/2009

Trial 31 Terminated 29-05-2009

Trial 32 4/5/2009

Trial 33 15-04-2009

Trial 34 16-04-2009

TEMP UTRN 071004305-100320095101078

CTRI/2009/091/000091, 03-09-2009

TEMP UTRN 052227973-28012009460856

CTRI/2009/091/000043, 13-10-2009

Open to recruitment

TEMP UTRN 011740523-02042009581207

CTRI/2009/091/000161, 09-06-2010

TEMP UTRN 071031378-13022009485959

CTRI/2009/091/000068, 24-09-2009

TEMP UTRN 090552197-230220094951008

CTRI/2009/091/000078, 04-03-2009

Open to recruitment

TEMP UTRN 035024123-130320095181087

CTRI/2009/091/000098, 29-05-2009

TEMP UTRN 075313930-190320095241079

CTRI/2009/091/000104, 04-05-2009

Open to recruitment

TEMP UTRN 045133155-25032009539178

CTRI/2009/091/000119, 15-04-2009

Open to recruitment

TEMP UTRN 020607659-260320095431032

CTRI/2009/091/000123, 16-04-2009

Closed to recruitment follow up continuing & closed to recruitment

Trial 35 31-03-2009

Trial 36 15-05-2009

Trial 37 27-05-2009

Trial 38 25-05-2009

Trial 39 4/5/2009

Trial 40 29-05-2009

Trial 41 10/7/2009

Trial 42 6/7/2009

Trial 43 20-08-2009

TEMP UTRN 042715053-26032009545874

CTRI/2009/091/000125, 31-03-2009


TEMP UTRN 124132731-220420096201211

CTRI/2009/091/000200, 15-05-2009

Open to recruitment

TEMP UTRN 033519060-150520097221180

CTRI/2009/091/000279, 27-05-2009

Open to recruitment

TEMP UTRN 052322236-150520097241180

CTRI/2009/091/000281, 25-05-2009

Open to recruitment

TEMP UTRN 114448674-240420096301078

CTRI/2009/091/000210, 04-05-2009


TEMP UTRN 030046461-270420096371165

CTRI/2009/091/000217, 29-05-2009


TEMP UTRN 061236763-150620098211532

CTRI/2009/091/000371, 10-07-2009

Open to recruitment

TEMP UTRN 040237171-200620098661475

CTRI/2009/091/000409, 06-07-2009


TEMP UTRN 111803469-22062009869178

CTRI/2009/091/000412, 20-08-2009


Trial 44 11/8/2009

Trial 45 21-07-2009

Trial 46 15-07-2009

Trial 47 23-07-2009

Trial 48 Terminated 17-08-2009


Trial 50 9/9/2009

Trial 51 27-07-2009


Trial 53 3/12/2009

TEMP UTRN 025630079-0108200910731078

CTRI/2009/091/000608, 11-08-2009

Open to recruitment

TEMP UTRN 024238822-300620099461444

CTRI/2009/091/000484, 21-07-2009


TEMP UTRN 100400826-030720099641332

CTRI/2009/091/000501, 15-07-2009


TEMP UTRN 110506197-060720099761734

CTRI/2009/091/000513, 23-07-2009


TEMP UTRN 110034575-09072009999235

CTRI/2009/091/000536, 17-08-2009

TEMP UTRN 045906401-080720099951735

CTRI/2009/091/000532, 12-08-2009

TEMP UTRN 032227767-0707200999036

CTRI/2009/091/000527, 09-09-2009

Open to recruitment

TEMP UTRN 100057840-08072009991744

CTRI/2009/091/000528, 27-07-2009

Open to recruitment

TEMP UTRN 050249236-090720091000859

CTRI/2009/091/000537, 09-12-2009

TEMP UTRN 093248354-1307200910091643

CTRI/2009/091/000546, 03-12-2009

Open to recruitment

Trial 54 30-07-2009

Trial 55 18-08-2009


Trial 57 29-01-2010

Trial 58 13-08-2009

Trial 59 24-09-2009

Trial 60 Completed 22-09-2009

Trial 61

Trial 62

TEMP UTRN 093633152-1407200910151032

CTRI/2009/091/000552, 30-07-2009

Open to recruitment

TEMP UTRN 054935881-290720091062602

CTRI/2009/091/000598, 18-08-2009

Open to recruitment

TEMP UTRN 032906743-150720091023832

CTRI/2009/091/000560, 03-09-2009

TEMP UTRN 114055429-2507200910541835

CTRI/2009/091/000590, 29-01-2010

Not yet recruiting

TEMP UTRN 105551367-1008200910971032

CTRI/2009/091/000632, 13-08-2009

Open to recruitment

TEMP UTRN 094148451-110820091102602

CTRI/2009/091/000636, 24-09-2009

Open to recruitment

TEMP UTRN 073509822-160820091124832

CTRI/2009/091/000656, 22-09-2009

Trial 63

Trial 64

Trial 65

Trial 66

Trial 67

Trial 68

Trial 69

Trial 70

Trial 71

Trial 72

Trial 73

Trial 74

Trial 75

Trial 76

Trial 77

Trial 78

Trial 79

Trial 80

Trial 81

Trial 82


Phase

9/14/2009 Diabetic 1 Phase 4


1/24/2008 Diabetic 200

7/17/2009 Diabetic Phase 3





Last Updated on


Public Title StudyWHO*


T. sample

sizeTo compare the efficacy and safety of a new formulation of telmisartan with the currently available formulation in the

A Randomized, Two Arm, Open Label, Comparative, single centre study to evaluate efficacy and safety of 2 generic formulations of

ALiskiren Trial In Type 2 diabetes Using cardiorenal Disease Endpoints

A randomized, double-blind, placebo-controlled, parallelgroup study to determine whether, in patients with type 2 diabetes at

A clinical trial to study the existence of reduced nerve mobility in old age individuals, comparing diabetic and non-diabetic subjects

Prevalence of Adverse Neural Tension in Geriatric Population With and Without Diabetes Mellitus- Study of Responses Elicited

Phase of Trial*

Effect of liraglutide or glimepiride added to metformin on blood glucose control in subjects with type 2 diabetes

Effect of liraglutide or glimepiride added to metformin on glycaemic control in subjects with type 2 diabetes

A Glycemic Control Evaluation of Glimepiride versus Rimonabant on Top of Metformin in Type 2 Diabetes

A Randomized, Double-Blind, Parallel-Group, Multicenter, Multinational Study to Assess Glycemic Control with Rimonabant in Comparison with

A clinical trial to study the effects of 2 Ayurvedic formulations, containing Ashwagandha, Brahmi and Amalaki on the physical and emotional well-being of elderly

A Proof of Concept prospective, double-blind, placebo controlled, comparative, randomized, parallel group, multi-centric clinical study to evaluate short-term

A clinical trial to study safety and activity of Ayurvedic formulation containing Ashwagandha and Haridra in patients with Type 2 Diabetes

A Proof of Concept prospective, double blind, placebo controlled, randomized, multi-¬centric study to evaluate the safety and activity of PHP-Diabetes

A clinical trial to assess the frequency of "low sugar" in the mother with elevated sugars (during pregnancy) using insulin aspart.

An open-label, prospective study to observe the incidence of hypoglycemia with insulin aspart in pregnant women with any degree of


6/3/2008 Diabetic 60 Phase 2/Phase 3

3/5/2010 Diabetic Phase 2/Phase 3




7/27/2009 Diabetic Not Applicable


A clinical trial to study the efficacy and safety of AVE0010 in patients with type 2 diabetes not treated with antidiabetic agents

A randomized, double-blind, placebo-controlled, parallel-group, multicenter 12-week study assessing the efficacy and safety

Role of a probiotic, VSL#3, in patients with nonalcoholic fatty liver disease.

Small intestine bacterial overgrowth and role of probiotic, VSL#3 in patients with nonalcoholic fatty liver disease

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD) (VIEW 2)

A randomized, double masked, active controlled, phase 3 study of the efficacy, safety, and tolerability of repeated doses of intravitreal VEGF Trap-

A clinical trial to study the effect of atorvastatin on pancreatic beta-cell function & insulin resistence in patients

A randomized double-blind placebo-controlled prospective evaluation of the effect of atorvastatin on pancreatic beta-cell

Effect of high dose vitamin B1 on early stage kidney disease in type 2 diabetes

A randomised, double-blind, placebo-controlled study to assess if high dose thiamine therapy of type diabetic patients

Evidence of Good Glycemic control in Conceptions through Assisted Reproduction Technology [EGG CART Study]

A Prospective, Monocentric, Open labelled, Multiple arm study on the influence of strict periconception glycemic control in women with various degrees of glucose intolerance in the

A clinical study to assess the effects of two drugs, atorvastatin and pioglitazone in patients of high blood pressure or angina, but

Effects of Atorvastatin and Pioglitazone on Endothelial Dysfunction in non-diabetic patients with hypertension or stable angina

Pilot Study Targeting Normal Glucose in Patients with Acute Myocardial Infarction through appropriate use of insulin therapy.

REsearching Coronary REduction by Appropriately Targeting Euglycemia ( Pilot Study): An International Multicentre Randomized Controlled Trial of Intensive Insulin


11/14/2008 Diabetic 100 Not Applicable


1/15/2009 Diabetic






Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes

A multicenter, double-blind, randomized, active controlled study to compare the effect of 52 weeks treatment with LAF237 50 mg bid to gliclazide up to 320 mg daily as add-on therapy in patients with type 2 diabetes

A clinical study to evaluate effect of surgery for control of Type2 diabetes in overweight individuals

A clinical trial of surgical treatment of Type2 Diabetes in non morbidly obese patients.

A clinical study to compare effects and safety Of recombinant Insulin Glargine manufactured by Biocon Ltd Compared to marketed Glargine

Open Label, Randomized, Multicentric Study To Establish Safety And Efficacy Of Recombinant Insulin Glargine Manufactured By Biocon

A clinical study to study the effects of the drug TZP-101 in patients with severe gastroparesis (delayed gastric emptying)due to Diabetes Mellitus

A Multicenter, Randomized, Double-Blind, Placebo-Controlled,Dose-Ranging Study to Assess the Efficacy and Safety of TZP-101 when

A clinical trial to study the blood sugar lowering effects and safety of oral insulin (IN-105 tablets) in patients of type 2 Diabetes Mellitus.

A Multicenter, Randomized, Double-Blind, Placebo Control Study of IN-105 tablets [oral insulin] in Patients with Type 2 Diabetes Mellitus who have

To assess the anti-diabetic effect of Vijayasar (extract of heartwood of - Pterocarpus marsupium) in the

Extended multicentric trial of Vijayasar (Pterocarpus marsupium) in the management of Type 2 Diabetes Mellitus.

A clinical trial to study the safety and effectiveness of a monoclonal antibody in combination with methotrexate in

A Randomized, Open label, Four Arms Parallel Study to Evaluate the Safety and Efficacy of anti-CD6 monoclonal antibody (T1h mAb) in

A clinical trial to study the safety and efficacy of a monoclonal antibody in patients with active psoriasis

A Phase II Study to Evaluate the Safety and Efficacy of anti-CD6 monoclonal antibody (T1h mAb) in Patients with Active Psoriasis.

A clinical trial to study the effects of 2 herbal products as dietary supplements for Male Sexual Health

A triple blind, randomized, double dummy, prospective placebo controlled dose determination study to investigate the safety and efficacy of E-MA-H







30-04-2009 Diabetic 100 Not Applicable

19-06-2009 Diabetic Phase 3


A Study for Patients With Type 2 Diabetes Mellitus

A 12-Week,Double-Blind, Placebo-Controlled Trial of LY2428757 in Patients With Type 2 Diabetes Mellitus

A Phase II clinical trial to study the effects of TRC4186, an investigational new drug in patients with stable heart failure associated with type 2 diabetes mellitus receiving oral anti-

Safety and Efficacy of TRC4186 in the treatment of stable heart failure associated with HbA1 ≥ 6.5% or type 2 Diabetes receiving oral hypoglycaemic therapy (with or without

Effect of insulin detemir and insulin glargine on blood glucose control in subjects with type 2 diabetes

A 26 week randomised, multinational, open labelled, 2 armed, parallel group, treat-to-target once daily treatment trial with insulin detemir versus

"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII Diabetes

"The effectiveness of a behavioral change communication model in promoting physical activity among females with typeII Diabetes

A clinical trial to study the effects of Ralfinamide in patients with chronic neuropathic low back pain.

EFFICACY AND SAFETY OF TWO FIXED DOSES (160 OR 320 MG/DAY) OF RALFINAMIDE IN PATIENTS WITH CHRONIC NEUROPATHIC LOW BACK PAIN. A

A clinical trial to study safety and efficacy of two drugs Insugen® R and Insugen® N with Actrapid® and Insulatard® in Patients with Type 1 Diabetes Mellitus.

A Randomized, Active Controlled, Parallel Group, Multi-Center, Two Stage, Open Label, Study Comparing Safety and Immunogenicity of Insugen® R and Insugen® N with

A randomized double blind active controlled parallel clinical trial to compare the effect of exercises(yogic/walking) on serum insulin level

The effect of various exercises yogic/walking on serum insulin level and glycemic control in patients with type 2 diabetes

Randomized, db, Placebo-Controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a

A Randomized, Double-Blind, Placebo-Controlled Parallel Group Efficacy and Safety Study of BI 1356 (5 mg Administered Orally Once Daily) Over

Efficacy and Safety Study of Alogliptin Compared to Glipizide in Elderly Diabetics

A Multicenter, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly

13-01-2010 Diabetic 792 Phase 3









A clinical Trial to compare the effects and safety of different combinations of the trial drug and metformin over 24 weeks in drug naïve or previously treated (after with

A phase III randomised, double-blind, placebo-controlled parallel group study to compare the efficacy and safety of twice daily administration of the free combination of BI

A comparison of various antioxidant preparations on insulin sensitivity in Type 2 diabetes patients

A study of comparative effects of Antioxidants on Insulin Sensitivity in type 2 diabetes mellitus: A Randomized Double Blinded Placebo-

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary

A Phase 2a, Randomized, Double Blind, Placebo-Controlled, Parallel Group Study Investigating The Dose-Response Of PF-00489791 On Acute

A Study Evaluating Efficacy And Safety Of PF-04523655 Versus Laser In Subjects With Diabetic Macular Edema (DEGAS)

A Phase II Prospective, Randomized, Multi-Center, Diabetic Macular Edema Dose Ranging, Comparator Study Evaluating the

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic

A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic

Evaluate Efficacy and Safety of Saxagliptin in Adult Indian Patients with Type 2 Diabetes inadequate glycemic control.

A 24-Week National, Multi-centre, Randomized, Parallel-group, Double-blind, Placebo-controlled, Phase IIIb study in India to Evaluate the Efficacy

Oral Insulin study for Type 2 Diabetes Mellitus

A Phase 2b, comparative, two arm randomized, placebo-controlled, double blinded multi-centric study to Evaluate the Safety, Tolerability, and

Infinnium-Core(TM) Registry: To Study the Saftey and efficacy of Infinnium-Core(TM) Coronary Stent for the treatment of New

Infinnium-Core(TM) Registry: Safety and Efficacy of the Infinnium-Core(TM) Paclitaxel-Eluting Coronary Stent System

A Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly to Those of Sitagliptin and a

A Randomized, Double-Blind, Parallel-Group, Multicenter Study to Compare the Glycemic Effects, Safety, and Tolerability of Exenatide




14-04-2010 Diabetic 20 Phase 2/Phase 3





14-01-2010 Diabetic Phase 2/Phase 3


A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

A Comparator-Controlled Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control (HbA1c) and Safety in Asian Subjects

Safety and Efficacy of Albiglutide in Type 2 Diabetes

A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Multicenter Study to Determine the Efficacy and Safety of Albiglutide When Used in Combination With

Long-Term Safety Study to Evaluate the Safety of Dutogliptin/PHX1149T in Subjects With Type 2 Diabetes Mellitus

An Open Label, Multi-Center, Long-Term Extension Study to Evaluate the Safety of Dutogliptin / PHX1149T in Subjects with Type 2

A clinical trial to evaluate the safety and efficacy of ReliDerm®DT in patients of non healing diabetic foot ulcer

To study the safety and efficacy of ReliDerm®DT in patients with chronic diabetic foot ulcer

Effects of Naturlose (Tagatose) on blood sugar Control and Safety of Naturlose Over One Year in Subjects with Type 2

Effects of Naturlose (Tagatose) on blood sugar Control and Safety of Naturlose Over One Year in Subjects with Type 2

Effect of Naturo fruit bars in type-II diabetes mellitus

Evaluation of the effect of Naturo fruit bars in patients with type-II diabetes mellitus

A clinical trial to study the safety and efficacy of 2mg and 4mg of ZYH1 compared to Pioglitazone 45mg in dyslipidemia with type 2

A multi-centric, randomized, double blind study to evaluate the safety and efficacy of 2mg and 4mg of ZYH1 compared to

A clinical trial to compare effect of Travoprost APS to TRAVATAN in patients with open-angle glaucoma or ocular

A multi-center, double-masked study of the safety and efficacy of Travoprost APS compared to TRAVATAN in patients with open-

A clinical trial to study the effect of prophylactic intravenous calcium in preventing neonatal early onset

Efficacy of prophylactic intravenous calcium administration in first 5 days of life in high risk neonates to prevent early onset neonatal

Study with HO/03/03 in the treatment of Plantar Neuropathic Diabetic Foot Ulcer.

Safety and efficacy of HO/03/03 in the treatment of Planatar Neuropathic Diabetic Foot Ulcers.




22-01-2010 Diabetic 20 Not Applicable


12/11/2009 Diabetic Phase 2/Phase 3


Efficacy and Safety of Alogiptin plus Metformin Compared to Glipizide plus Metformin in Subjects with Type 2 Diabetes Mellitus.

A Multicenter, Randomized, Double-Blind, Active ? Controlled Study to Evaluate the Durability of the Efficacy and Safety of Alogliptin Compared to Glipizide

A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)

A 12-week multi-center, randomized, double-blind, placebocontrolled, parallel-group adaptive design study to

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with

Evaluation of Safety and Efficacy of Mersina, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with

Clinical trial to study the safety and efficacy of stemcell therapy in patients with heart diseases

Stem cell therapy- Cellular Cardio myoplasty for patients with heart diseases

A clinical trial to study the effects of Naturlose (Tagatose) in patients with mild type 2 Diabetes Mellitus under control with Diet and Exercise over a period

Dose Ranging Effects of Three Low-doses of Naturlose? (Tagatose) on Glycemic Control and Safety of Naturlose? (Tagatose) Over Six Months in

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration in Metformin Monotherapy Treated Type 2 Diabetic Patients

Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of an Ayurvedic

Formulation Limit for safety and efficacy in type 2 diabetic patients with oral drug failure

Evaluation of Safety and Efficacy of Limit, an Ayurvedic formulation: A double blind, placebo controlled study in type 2 diabetic patients with


1

20

1

25 Lakshmi Hospital, Lakeshore Hospital

2 Diacon Hospital

4

4

1

Esti trial duration

total Sites no

Years Shree Hari Diabetes Foundation

4 Years Poona Hospital & Research Centre,


Madras Diabetic Research Foundation

Topiwala National Medical College & BYL Nair Hospital

2 Years Dept of Physiotherapy

Months Kerala Institute of Medical Sciences (KIMS)

M.V.Diabetes Care & diabetes Research Centre

1 Years Medisys Clinisearch India PVT Ltd

12 Months TNMC & BYL Nair Hospital, Mumbai Central, Mumbai 400 008

Seth G.S. Medical College & KEM Hospital, Parel, Mumbai 400 012

Deccan College of Medical Sciences & Allied hospitals,Kanchanbhag Santoshnagar,Hyderabad-500058

Vydehi Institute of Medical Science and Research Centre, 82, EPIP area, Whitefield. Bangalore-560006

12 Months TNMC & BYL Nair Hospital, Mumbai Central, Mumbai 400 008

Seth G.S. Medical College & KEM Hospital, Parel, Mumbai 400 012

Vydehi Institute of Medical Science and Research Centre, 82, EPIP area, Whitefield. Bangalore-560 00

Deccan College of Medical Sciences & Allied hospitals,Kanchanbhag Santoshnagar,Hyderabad-500058

3 Years MADHAV DIABETES CENTRE

4 Manipal Hospital

2 Dept. of Hepatology

15

1

1

1 Prashanth Hospital

2

17 Nanjappa Hospital

Diabetes Thyroid Research Institute Pvt Ltd

Bhagwan Mahaveer Jain Hospital

Medilink Research Centre

3 Years Dept. of Gastroenterology and HNU, AIIMS

Years Aravind Eye Hospital

Dr.R.P Center for Ophthalmic Sciences

Aravind Eye Hospital


12 Months OPD, Department of Endocrinology & Metabolism, AIIMS, New Delhi

5 Months Sheikh Zayed Federal Postgraduate Medical Institute

4 Years

Months All India Institute of Medical Sciences


2 Years Department of Cardiology, St. Johns Medical College & Hospital


Southern Railway HQ Hospital

8

1 Bombay Hospital

15

1

16 Diacon Hospital

4

10

9 Manipal Hospital Bowring Hospital PSG Hospital

6

Years S. R. Kalla Memorial Gastro & general Hospital

M.S. Ramaiah Memorial Hospital

Christian Medical College,


3 Years

Months Samatvam Endocrinology Centre,No:2 , First A Cross Road,Maranhalli, JP Nagar IInd Phase, Bangalore

St. Johns college and hospital, Sarjapur Road, Bangalore.

Medwin Hospitals,Chirag Ali Lane,Hyderabad

Sterling Hospital,Sterling Hospital Road, Mem Nagar,Ahmedabad

Amrita Institute of Medical Sciences and Research Center, Amrita Lane, Elamakkara PO, Cochin, Kerala

Months M.S. Ramaiah Memorial Hospital

St.John's medical College and Hospital

Mediheights Healthcare Pvt Ltd

2 Years S C B Medical college

Medical college Hospital

madras medical college

All India Institute of Medical Sciences (AIIMS)

Months Chanre Rheumatology & Immunology Centre & Research (CRIC&R)

Center For Rheumatic Diseases

L T M Medical College & L T M G Hospital

Institute of Post Graduate Medical Education & Research

Months M S Ramaiah Memorial Hospital

Years Balaji Clinic, Main Road, Devipada, Borivali (E)

169, Parvati gaon, Bhagirathi Medical Foundation

Pungaliya Hospital, opp veer savarkar bhavan, Shivaji Nagar

Sector 27 A/150, Nigadi pradhikaran

6

6 CARE Hospital

2

1

21

8

1 Mittal Hospital

8

4

Lady Ratan Tata Medical Research Center

Bhagwan Hahavir Jain Hospital

Instride Research Institute

Dr. V Seshiah Diabetes Care and Research Institute



Shri Ram Cardiac Center

26 Weeks Months

Swamy Diabetes Centre

Jothydev Diabetes and Research Centre

4 Months Diabetic clinic OP,Thiruvananthapuram medical college

Years Sri Ramachandra medical College, Chennai

Vijaya Health Centre, Chennai

Nizams Institute of Medical Sceinces, Hyderabad

CARE hospital, Hyderabad

24 Months Postgraduate Institute of Medical Education & Research,Sector 12, Chandigarh 160 012

Belgaum Diabetes Center,2nd Floor, Maruti Galli,Belgaum 590 001

Department of Endocrinology,diabetes and Metabolism ,Christian Medical College Hospital,

Bangalore Diabetes Hospital, No 16/M Thimmaiah Road, Miller Tank Bed Area, Vasanthnagar,

3 Months

Months M. S. Ramaiah Hospital

Diabetes Thyroid Hormone Research Institute

Dr. V Seshiah Diabetes Care and Research Institute - Department of Endocrinology

Department of Endocrinology, Bhagwan Mahaveer Jain Hospital

Years Belgaum Diabetes Centre

Bhagwan Mahavir Jain Hospital

Bharti Research Institute of Diabetes and Endocrinology

IRL Research Centre

19 Kasturba Hospital

1

3

4

6 S.R. Kalla Hospital

13 Ruby Hall Clinic Bharti Hospital

3

9

8

168-175 Days Diacon Hospital Diabetes care & Research Center

V Seshiah Diabetics Care and Research Center

Jnana Sanjeevani Medical Center

Months Diabetes OPD Sassoon Hospital

8 Months Bankers Heart Institute

Department Of Cardiology, Sri Venkateswara Institute Of Medical Sciences

Department Of Cardiology, MediCiti Hospital,

Months Eye Research Center & Retina Foundation

Dr. Rajendra Prasad Centre for Ophthalmic Sciences,All India Institute of Medical Sciences

Vittala International Institute of Ophthalmology

L.V. Prasad Eye Institute

Gujarat Endocrine Center

Coimbatore Diabetes Foundation


20 Months Diabetes Thyroid Hormone Research Institute Pvt. Ltd.


56 Days Jnana sanjeevini diabetes center

samatvam : endocrinology diabetes center

Endocrinology Diabetes Centre

2 Years Baroda Heart Institute & Research Center, Vadodara

Government Medical College & Super Speciality Hospital, Nagpur

Arneja Heart Institute, Nagpur

Bankers Heart Institute, Vadodara

3 Years Chowpatty Medical Centre

Bhagwan Mahaveer Jain Hospital


King Edward Memorial Hospital

14

8

10 CARE Hospitals Bhatia Hospital Shivam Clinic

7

25

1

13

5

1

9

Gujarat Endocrine Center


Jawaharlal Nehru Medical College

The Bangalore Diabetes Hospital

Years Gokula Metropolis Clinical Research Center, M. S. Ramaiah Memorial Hospital,

Dande Diabetes and Heart Care,

Bangalore Diabetes Centre


3 Years Pitale's Clinic, Diabetes and hormone centre

10 Months Dande Diabetes & Heart Care Centre

Pravara Institute of Medical Sciences

Dhanwantari Hospita

Joshi Hospital, Maharashtra Medical Society

3 Years Suyash Hospital Pvt Ltd

St. John's Medical College Department of Endocrinology

Aware Global hospital, Hyderabad

Pallakad diabetic Center

6 Months Consultant Physician & Diabetologist

Months Le Bonheur Endocrine & Diabetes Clinic

Pai Clinic & Diagnostic Centre

DHL Research Centre,

Sudeep Diabetes Care Centre,

8 Months Aravind Eye Hospital


National institute of Ophthalmology

Convest Jain clinic group of hospitals

Months Department Of Pediatrics,LLRM Medical College,Meerut(U.P),INDIA

15 Months Jain Institute of Vascular Sciences,

Dr. V Seshiah Diabetes Research Institute

Sir Ganga Ram Hospital,

S.K Diabetes & research Center

10 Medwin Hospital Diabetomics

5

1

1

10

12

1

Years Trichy Diabetic Speciality Center

Research Health Institute in Diabetes, Endocrinology & Metabolism (RHIDEM)

Years Fortis Flt Lt Rajan Dhal Hospital


Diabetes Thyroid Hormone Research Institute (DTHRI)

INSTITUTE OF CLINICAL ENDOCRINOLOGY AND DIABETES CARE UNIT

Months Jyoti Clinical & Pathological Laboratory

6 Months Frontier Lifeline Pvt.Ltd

1 Months Bangalore Endocrinology and Diabetes Research Centre

Diabetes Thyroid Hormone Research Institute Pvt. Ltd.

Diabetes Care and Research Centre

Krishna Diabetes Clinic and Educational Research Centre

Years Amrita Institute of Medical Sciences




3 Months Jyoti Clinical & Pathological Laboratory

Site 5 Site 6 Site 7 Site 8 Site 9

Medwin hospitals, Lotus DiagnosticsInstitute of Post Graduate Medical Education & Research and SSKM Hospital

M V Hospital for Diabetes and Diabetic Research Center


Arthur Asirvatham Hospital

Dr. V Seshiah Diabetes Care

Diabetes Care & Research Centre,

Cuttack Diabetes Research Foundation,

Rama Krishna Mission Seva Prathisthan

Advance Eye Center Retina FoundationLittle Flower Hospital Trust

Aditya Jyot Eye Hospital

Regional Institute Of Ophthalmlogy

Post Graduate Institute of Medical Sciences

Mahatma Gandhi Institute of Medical Sciences

KEM Hospital & Seth G.S Medical College

Life Worth Super Speciality Hospital

Baby Memorial Hospital

DiabetOmics India.

Apollo Hospital SRMC

Diabetes Thyroid Hormone Research Institute Pvt. Ltd.

Bharti Research Institute of Diabetes and Research

Medilink Research Centre

All India Institute of Diabetes & Research

Belgaum Diabetes Hospital,Ground floor, Maruthigalli,Belgaum

Bangalore Diabetes Hospital,LNo 16/M,Thimmaiah Road,Vasanthnagar Bangalore

Mediheights Health Care Private Limited, Opp Ajanta Pharma,Hindustan Naka, Kandivli West, Mumbai

Dr.V.Seshiah Diabetes Care& Research Institute,No.31 A, Ormes Road, Kilpauk,Chennai

Endocrinology Diabetes Centre,640 First main First Stage Indiranagar,Bangalore

JSS Medical College Hospital

Postgraduate Institute of Medical Education & Research


Shri Ramachandra Medical College & Research Institute




BYL Nair Charitable Hospital,

Shubhechha Multispecialty Hospital

Owaisi Hospital and Research Centre


Shubhechha Multispeciality Hospital

INSTRIDE, 6 poonam arcade,1170/11 revenue colony, J.M Road Shivaji Nagar,

Behind Hotel Vasco, Nasik Road

Cosmopolitan Medical Care Center

Associates in Clinical Endocrinology Education and Research



Owasis Hospital & Research Center, Hyderabad

J.S.S.hospital, Mysore

St. John's Medical College and Hospital, Bangalore

M.S.Ramaiah Memorial Hospital, Bangalore

Kovai Medical Centre and Hospital, Coimbatore

Diabetes Unit,KEM Hospital Research Center,6th Floor Banoo Coyaji Bldg,Sardar Moodliar Road,

Department of Endocrinology and Metabolism,Room # 311, 3rd Floor ,AIIMS,New Delhi - 110029

Diabetomics India,6-3-349/ 17B ,Hindi Nagar,Banjara hills PO,Hyderabad- 500034

Orange Diabetes Specialty Clinic

K.G.N. Diabetes and Endocrine Centre

Pitale Diabetes and Hormone Centre

Department of Endocrinology, Jawaharlal Nehru Medical College and Hospital

B.P Poddar Hospital and Medical Research


S.R Kalla Memorial Gastro and General Hospital

Dande Diabetes & Heart Care Centre,

Diabetes Care & Research Centre,

The Bangalore Diabetes Hospital

Bangalore Endocrinology and Diabetes Research Centre


Medisys Clinisearch India Pvt Ltd.

Diabetes Care & Research Institute


Lotus Diagnostic Centre

CHL Apollo Hospitals, Indore.

Sri Ramakrishna Heart Foundation & Research Centre, Coimbatore




Bharti Research Institute of Diabetes and Endocrinology (BRIDE), Bharti Hospital


Mediheights Health Care Pvt Ltd

Samatvam, Science & Research for Human Welfare Trust

Care Hospital

KEM Hospital

Endocare Clinic ACEER

Akshay Hospital

D,Clinarch Diabetomics

Shroff Eye Hospital

Patil Hospital

King Edward VII Memorial Hospital

M S Ramaiah Medical College Hospital


Banaras Hindu University



M.V. Hospital For Diabetes Pvt. Ltd.


Medisys Clinisearch India Pvt. Ltd. (Bangalore Diabetes centre)

Bhagawan Mahaveer Jain Hospital

Poona Hospital & Research Center

J. N. Medical College, KLE Hospital & Research Center

Department of Medicine

Sai Venketeshwara hospital

Padmasree Diagnostics

Standard Laboratory and Polyclinic

Aruna Diabetes Centre

Post-Graduate Institute of Medical Education & Research (PGIMER)

B.J. Medical College & Civil Hospital,

HCG Medisurge Hospital

Karnataka Institute of Diabetology

St. John's Medical College & Hospital

MV Hospital for Diabetes Pvt Ltd

Om shree Swami samarth hospital

Endocare Clinic

Krishna Diabetes Clinic and Educational Research Centre

Bangalore Endocrinology and Diabetes Research Center (BEDRC)

Belgaum Diabetes Centre

Diabetes Care & Research Center


GOVT MEDICAL COLLEGE

Medisys Clinisearch India Pvt. Ltd.

Bharti Research Institute of Diabetes and Endocrinology

Belgaum Diabetes Centre

Research Health Institute in Diabetes


Nizam?s institute of Medical Sciences

Pitale Diabetes & Hormone centre

Samatvam: Endocrinology Diabetes Centre

S.R Kalla Memorial Hospital


Park Clinic

M S Ramaiah Memorial Hospital

St.Johns Medical College

Kasturba Medical College

Dr V Seshiah Diabetes Care and Research Institute,

Amrita Institute of Medical Sciences and Research Centre

Apollo Gleneagles Hospitals Ltd

Manipal Acunova Clinical Research Centre (Manipal Hospital)

Medilink Research Basement

P.D. Hinduja National Hospital & Research Center

Narayana Netralaya

P.S.G Hospital Care Hospital

Vision Research Foundation



Dr. Shroff?s Charity Eye Hospital

Avanti Institute of Cardiology Pvt.Ltd

Assam MEdocal College & Hospital

Dr. B.R. Patel Hospital

Nizam's Institute of Medical Sciences, Dept of Endocrinology and Metabolism, Punjagutta,Hyderabad

Mediciti Hospital, 5-9-22, Secretariat Road,Hyderabad

KEM Hospital,Sardar Moodliar Road,Pune

Diabetes Clinic and Research Centre,Shreeniwas Opp Dhantoli Park,Nagpur

Apollo Hospitals International Limited, Ahm-1A, Bhat GIDC Estate-Ahmedabad

Dr V Seshiah Diabetes Care and Research Institute

Health and Research Center

Gandhi Research Institute

BYL Nair Ch. Hospital

JNANA SANJEEVINI MEDICAL CENTER

Sparsh Orthopaedic Hospital

Brain and Mind Institute, Nagpur

Neuro Care Centre, Lucknow

Baby Memorial Hospital, Calicut

Mallikatta Neuro and Research Centre, Mangalore

Deenanath Mangeshkar Hospital and Reserch center, Pune

K G Hospital Sterling Hospital

St. John Medical College Hospital,


Sunil's Diabetic Care and Research Centre

Research Health Institute in Diabetes,

Health and Research Centre,

Diabetes Unit 6TH Floor


DIACARE

Rudrawadi Hospital

Mediciti Hospital Global Hospitals Medwin Hospitals

Dia-care Clinic

IPGMER and SSKM Hospital

Dr Vaishnavas Diabetes Clinic


Hormone Care and Research Centre


Trichy Diabetes Speciality Center (P) Ltd

Bangalore Endocrinology and Diabetes Centre

St. John?s Medical College & Hospital

Bharti research institute of Diabetes and Endocrinology

Sunil's Diabetes care and Research Centre

Gokula Metropolis Clinical Research Centre

King George Hospital



KEM Hospital Mediciti Hospitals Care Hospital Nizams Institute of Medical Sciences

Osmania General Hospital

Orange Diabetes Speciality Clinic

Prince Aly Khan Hospital,

Endocrine and Diabetes Centre


Hormone Care Centre

Shroff Eye Hospital

Shreenath Hospital Krishna Institute of Medical Sciences Ltd

Dept of Medicine, JSS Medical College Hospital ,Ramanuja Road, Agrahara, Mysore


Dayanand Medical college & hospital, Ludhiana

Apollo Hospitals, Hyderabad

Neurology Centre , Ahemdabad

Ruby General Hospital, Kolkata

Pankaj Gupta Clinic, Jaipur

Apollo Hospital,Indraprastha Apollo Hospital


Diabetologist Spectra Research Clinical Centre,

Krishna Diabetes Clinic and Educational Research Centre,

ACEERCoimbatore Diabetes Foundation

Health and Research Division


Hubli Clinical research Center


Mediciti Hospitals Medwin Hospitals

Life care Institue of Medical Sciences & Research

Pushpawati Singhania Research Institute

Diabetes, Thyroid and Endocrine Centre

Krishna Institute of medical sciences Ltd

Diacon Hospital and Research Centre

Moses Diabetes and Medical Center

Sunil's Diabetes Care Research

Sunil's Diabetes Care Research

Site 25

Mediheights Healthcare Private Limited

ctri data base india icmr

Documents